deferoxamine has been researched along with Bronze Diabetes in 281 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Deferiprone (L1), and appropriate combinations with deferoxamine (DFO), can be used effectively for the treatment of thalassemia and other transfusional iron loading conditions." | 8.83 | Future chelation monotherapy and combination therapy strategies in thalassemia and other conditions. comparison of deferiprone, deferoxamine, ICL670, GT56-252, L1NAll and starch deferoxamine polymers. ( Kontoghiorghes, GJ, 2006) |
| "Deferoxamine, an iron chelating agent, has been used for the treatment of hemochromatosis for more than 30 years." | 7.69 | [Ocular side effects of deferoxamine therapy in aplastic anemia with transfusion-induced hemochromatosis]. ( Lang, GE; Schicketanz, C; Spraul, CW, 1996) |
| "A number of studies have shown that regular chelation therapy with deferoxamine is effective in patients with secondary hemochromatosis." | 7.69 | [Long-term efficacy of subcutaneous administration of deferoxamine in patients with secondary hemochromatosis]. ( Fujisawa, S; Kobayashi, M; Yano, K, 1996) |
| "The nature of non-transferrin-bound iron in the plasma or serum of iron-overloaded hemochromatosis patients was studied by high performance liquid chromatography (HPLC) and high resolution nuclear magnetic resonance (NMR)." | 7.67 | Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. ( Aruoma, OI; Bell, JD; Bomford, A; Grootveld, M; Halliwell, B; Sadler, PJ, 1989) |
| "Gallium scintigraphy was performed as an aid for determining the presence or absence of malignant neoplasm in two patients with hemochromatosis treated by deferoxamine." | 7.67 | Gallium-67 scintigraphy in patients with hemochromatosis treated by deferoxamine. ( Hoshi, H; Jinnouchi, S; Nagamachi, S; Ono, S; Watanabe, K, 1988) |
| "Hemochromatosis was diagnosed in a 14-year-old, male, red ruffed lemur (Varecia variegata ruber) on the basis of abnormal results of serum biochemical analysis, including high serum ferritin and transferrin saturation values, and of liver biopsy." | 5.32 | Use of desferoxamine and S-adenosylmethionine to treat hemochromatosis in a red ruffed lemur (Varecia variegata ruber). ( Montali, RJ; Murray, S; Sanchez, CR, 2004) |
| "Deferoxamine was given subcutaneously for 14 months." | 5.26 | Use of subcutaneous deferoxamine in a child with hemochromatosis associated with congenital dyserythropoietic anemia, type I. ( Perrault, J; Smithson, WA, 1982) |
| "All of 34 patients with untreated hemochromatosis had distinctly elevated values for deferoxamine-chelatable iron." | 5.26 | Deferoxamine-chelatable iron in hemochromatosis and other disorders of iron overload. ( Baggenstoss, AH; Baldus, WP; Dickson, ER; Fairbanks, VF, 1978) |
| " The dosage of deferoxamine mesylate was altered every 48 hours from 1 g/sq m/24 hr to 2 or 4 g/sq m/24 hr." | 5.26 | Continuous intravenous deferoxamine infusion. Treatment of secondary hemochromatosis in adults. ( Beutler, E; Blume, KG; Chillar, RK; Fahey, JL; Sharkoff, D; Zia, PK, 1978) |
| "Deferiprone (L1), and appropriate combinations with deferoxamine (DFO), can be used effectively for the treatment of thalassemia and other transfusional iron loading conditions." | 4.83 | Future chelation monotherapy and combination therapy strategies in thalassemia and other conditions. comparison of deferiprone, deferoxamine, ICL670, GT56-252, L1NAll and starch deferoxamine polymers. ( Kontoghiorghes, GJ, 2006) |
| "Deferoxamine (DFO) is a chelating agent used widely for the treatment of transfusional hemochromatosis." | 3.74 | Deferoxamine-related ocular toxicity: incidence and outcome in a pediatric population. ( Baath, JS; Chun, A; Kirby, M; Lam, WC, 2008) |
| " It is also the second case report of a Pearson patient suffering from severe iron overload and liver disease that responded to therapy with deferoxamine." | 3.74 | Pearson syndrome in an infant heterozygous for C282Y allele of HFE gene. ( Augoustides-Savvopoulou, P; Farmaki, E; Karatza, E; Kefala-Agoropoulou, K; Lazaridou, A; Roilides, E; Tsantali, H; Tsiouris, J, 2007) |
| "A number of studies have shown that regular chelation therapy with deferoxamine is effective in patients with secondary hemochromatosis." | 3.69 | [Long-term efficacy of subcutaneous administration of deferoxamine in patients with secondary hemochromatosis]. ( Fujisawa, S; Kobayashi, M; Yano, K, 1996) |
| "Deferoxamine, an iron chelating agent, has been used for the treatment of hemochromatosis for more than 30 years." | 3.69 | [Ocular side effects of deferoxamine therapy in aplastic anemia with transfusion-induced hemochromatosis]. ( Lang, GE; Schicketanz, C; Spraul, CW, 1996) |
| "Deferoxamine is still today the only preventive and curative treatment of transfusional hemochromatosis." | 3.68 | [Intensifying iron chelating therapy with desferrioxamine using implantable venous access catheters (Port-A-Cath)]. ( Clairicia, M; de Montalembert, M; Girot, R; Hannedouche, T; Jan, D; Sidi, D, 1992) |
| "Three iron-containing fractions were detected by high-performance liquid chromatography (HPLC) on a reverse-phase column in the 24-h urine of two patients with hereditary hemochromatosis following the injection of deferoxamine mesylate (Desferal)." | 3.68 | Ferrioxamine and its hexadentate iron-chelating metabolites in human post-desferal urine studied by high-performance liquid chromatography and fast atom bombardment mass spectrometry. ( Heinrich, HC; Lehmann, WD, 1990) |
| "The nature of non-transferrin-bound iron in the plasma or serum of iron-overloaded hemochromatosis patients was studied by high performance liquid chromatography (HPLC) and high resolution nuclear magnetic resonance (NMR)." | 3.67 | Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. ( Aruoma, OI; Bell, JD; Bomford, A; Grootveld, M; Halliwell, B; Sadler, PJ, 1989) |
| "Gallium scintigraphy was performed as an aid for determining the presence or absence of malignant neoplasm in two patients with hemochromatosis treated by deferoxamine." | 3.67 | Gallium-67 scintigraphy in patients with hemochromatosis treated by deferoxamine. ( Hoshi, H; Jinnouchi, S; Nagamachi, S; Ono, S; Watanabe, K, 1988) |
| "Hemochromatosis is a common genetic disorder in which iron may progressively accumulate in the liver, heart, and other organs." | 2.46 | How I treat hemochromatosis. ( Adams, PC; Barton, JC, 2010) |
| "Iron overload is characterized by excessive iron deposition and consequent injury and dysfunction of the heart, liver, anterior pituitary, pancreas, and joints." | 2.44 | Chelation therapy for iron overload. ( Barton, JC, 2007) |
| "Hemochromatosis is a syndrome which, when fully expressed, is manifested by melanoderma , diabetes mellitus, and liver cirrhosis, with iron overload involving parenchymal and reticuloendothelial cells in many organ systems." | 2.36 | Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy. ( Kellermeyer, RW; McLaren, GD; Muir, WA, 1983) |
| "Juvenile hemochromatosis is the most severe form of iron overloading phenotype." | 1.48 | Reversal of end-stage heart failure in juvenile hemochromatosis with iron chelation therapy: a case report. ( Cooray, SD; Hamblin, PS; Heerasing, NM; Leet, AS; McDonald, CJ; McLean, CA; McNamara, E; Roberts, SK; Selkrig, LA; Subramaniam, VN, 2018) |
| "Diabetes insipidus is a rare disorder in pregnant women, predating pregnancy or appearing for the first time during gestation." | 1.36 | Recurrent pregnancy-induced diabetes insipidus in a woman with hemochromatosis. ( Kobielusz-Gembala, I; Krysiak, R; Okopien, B, 2010) |
| "He was diagnosed with aplastic anemia at 11-yr of age." | 1.35 | Complete hematopoietic recovery after continuous iron chelation therapy in a patient with severe aplastic anemia with secondary hemochromatosis. ( Han, CW; Park, SJ, 2008) |
| "Patients with beta-thalassemia major often present with severe anemia and must undergo continuous transfusion therapy, consequently developing iron overload leading to hemochromatosis." | 1.33 | Lack of prognostic value of normalized integrated backscatter analysis of myocardium in patients with thalassemia major: a long-term follow-up study. ( Ait-Ali, L; Bellotti, P; Derchi, G; Forni, G; Jambrik, Z; Picano, E, 2005) |
| "Type 3 hemochromatosis is a rare autosomal recessive disorder due to mutations of the TFR2 gene." | 1.32 | Type 3 hemochromatosis and beta-thalassemia trait. ( Arosio, C; Bovo, G; Mariani, R; Pelucchi, S; Piperno, A; Riva, A; Salvioni, A; Vergani, A, 2004) |
| "Hemochromatosis was diagnosed in a 14-year-old, male, red ruffed lemur (Varecia variegata ruber) on the basis of abnormal results of serum biochemical analysis, including high serum ferritin and transferrin saturation values, and of liver biopsy." | 1.32 | Use of desferoxamine and S-adenosylmethionine to treat hemochromatosis in a red ruffed lemur (Varecia variegata ruber). ( Montali, RJ; Murray, S; Sanchez, CR, 2004) |
| "In acute B19 parvovirus infections an underlying hematologic disease should be excluded." | 1.31 | [An older female patient with refractory anemia and hemochromatosis]. ( Ceconi, C; Fabel, H; Flemming, P; Schuppert, F; Sutor, GC; Wysk, J, 2002) |
| "Juvenile hemochromatosis is a rare genetic disorder that causes iron overload." | 1.31 | Juvenile hemochromatosis associated with B-thalassemia treated by phlebotomy and recombinant human erythropoietin. ( Brunello, F; Camaschella, C; De Gobbi, M; Mazza, U; Paccotti, P; Pasquero, P, 2000) |
| "Juvenile haemochromatosis is a rare inborn error of iron metabolism with clinical manifestations before 30 years of age." | 1.30 | Hereditary juvenile haemochromatosis: a genetically heterogeneous life-threatening iron-storage disease. ( Cox, TM; Kelly, AL; Rhodes, DA; Roland, JM; Schofield, P, 1998) |
| "Neonatal hemochromatosis was diagnosed in 14 patients between 1985 and 1995." | 1.30 | Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies. ( Hansen, TW; Knisely, AS; Kocoshis, SA; Reyes, J; Rosh, J; Sigurdsson, L, 1998) |
| "Six patients had clinical evidence of delayed puberty with spontaneous and stimulated gonadotropin and sex steroid levels appropriate for their delayed pubertal stage." | 1.29 | Multiple hormone deficiencies in children with hemochromatosis. ( Cassorla, FG; Kamp, GA; Manasco, PK; Munson, PJ; Nienhuis, AW; Oerter, KE, 1993) |
| "Cardiac involvement in hereditary haemochromatosis (HH) is a poor prognostic sign and is the main cause of death in the juvenile form." | 1.29 | Heart transplantation in a case of juvenile hereditary haemochromatosis followed up by MRI and endomyocardial biopsies. ( Baandrup, U; Bagger, JP; Christensen, T; Ellegaard, J; Jensen, FT; Jensen, PD, 1993) |
| "Idiopathic hemochromatosis is frequently associated with various malignancies including hepatic carcinoma." | 1.28 | [A case of idiopathic hemochromatosis associated with gastric cancer]. ( Akagi, K; Fujishima, M; Ishitsuka, T; Nomiyama, K; Okamura, T; Shibuya, T; Sugie, Y; Tsuji, H, 1992) |
| " The dosage and the route of administration (IV, IM, SC) were adapted to the amount of iron transfused and to the nature of the disease." | 1.28 | [Treatment of post-transfusion iron overload by deferoxamine]. ( de Montalembert, M; Girot, R; Hannedouche, T; Llados, A, 1989) |
| "Severe congestive cardiac failure developed in a few weeks in a 44 year old man who had undergone porto-caval anastamosis for post-hepatitis cirrhosis one year previously and then treated for anaemia by repeated blood transfusion and chronic daily oral iron therapy." | 1.27 | [Adiastole caused by a secondary cardiac hemochromatosis. Successful treatment with an iron chelating agent]. ( Azancot, I; Baudouy, P; Lombrail, P; Martin, E; Piekarski, A; Slama, R, 1983) |
| " In the patients, only a single phase of decline was observed, with a half-life of 5." | 1.27 | Pharmacokinetics and renal elimination of desferrioxamine and ferrioxamine in healthy subjects and patients with haemochromatosis. ( Allain, P; Ang, KS; Cam, G; Chaleil, D; Le Mignon, L; Mauras, Y; Simon, M; Simon, P, 1987) |
| "33 patients with chronic renal failure were divided into two groups." | 1.26 | [Iron-overload in patients on maintenance hemodialysis: diagnostic criteria, indications and treatment by desferrioxamine (author's transl)]. ( Bonn, F; Guezennec, M; Simon, P; Tanquerel, T, 1981) |
| "Deferoxamine was given subcutaneously for 14 months." | 1.26 | Use of subcutaneous deferoxamine in a child with hemochromatosis associated with congenital dyserythropoietic anemia, type I. ( Perrault, J; Smithson, WA, 1982) |
| "All of 34 patients with untreated hemochromatosis had distinctly elevated values for deferoxamine-chelatable iron." | 1.26 | Deferoxamine-chelatable iron in hemochromatosis and other disorders of iron overload. ( Baggenstoss, AH; Baldus, WP; Dickson, ER; Fairbanks, VF, 1978) |
| "Idiopathic hemochromatosis is an iron-storage disease more common in men than in women." | 1.26 | Idiopathic hemochromatosis: case report of a patient presenting with neurologic symptoms. ( Afrooz, N; Sinclair, WP, 1977) |
| " The dosage of deferoxamine mesylate was altered every 48 hours from 1 g/sq m/24 hr to 2 or 4 g/sq m/24 hr." | 1.26 | Continuous intravenous deferoxamine infusion. Treatment of secondary hemochromatosis in adults. ( Beutler, E; Blume, KG; Chillar, RK; Fahey, JL; Sharkoff, D; Zia, PK, 1978) |
| "One case of transfusion haemochromatosis with haemolytic anaemia and renal failure gave an Fv value of 8,019 mug." | 1.24 | Differential ferrioxamine test in idiopathic haemochromatosis and transfusional haemosiderosis. ( Brunström, GM; Fielding, J; O'Shaughnessy, MC, 1966) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 200 (71.17) | 18.7374 |
| 1990's | 45 (16.01) | 18.2507 |
| 2000's | 26 (9.25) | 29.6817 |
| 2010's | 9 (3.20) | 24.3611 |
| 2020's | 1 (0.36) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, W | 1 |
| Xiao, Y | 1 |
| Zhao, C | 1 |
| Zhang, Z | 1 |
| Liu, W | 1 |
| Ma, J | 1 |
| Ganz, T | 1 |
| Zhang, J | 1 |
| Liu, S | 1 |
| Cooray, SD | 1 |
| Heerasing, NM | 1 |
| Selkrig, LA | 1 |
| Subramaniam, VN | 1 |
| Hamblin, PS | 1 |
| McDonald, CJ | 1 |
| McLean, CA | 1 |
| McNamara, E | 1 |
| Leet, AS | 1 |
| Roberts, SK | 1 |
| Lee, JA | 1 |
| Tchantchaleishvili, V | 1 |
| Vidula, H | 1 |
| Pretorius, E | 1 |
| Bester, J | 1 |
| Vermeulen, N | 1 |
| Lipinski, B | 1 |
| Gericke, GS | 1 |
| Kell, DB | 1 |
| Nijjar, PS | 1 |
| Vongooru, H | 1 |
| Tamene, A | 1 |
| Valeti, U | 1 |
| Masri, C | 1 |
| Tauchenová, L | 1 |
| Křížová, B | 1 |
| Kubánek, M | 1 |
| Fraňková, S | 1 |
| Melenovský, V | 1 |
| Tintěra, J | 1 |
| Kautznerová, D | 1 |
| Malušková, J | 1 |
| Jirsa, M | 1 |
| Kautzner, J | 1 |
| Baath, JS | 1 |
| Lam, WC | 1 |
| Kirby, M | 1 |
| Chun, A | 1 |
| Adams, PC | 1 |
| Barton, JC | 2 |
| Cario, H | 1 |
| Grosse, R | 1 |
| Janssen, G | 1 |
| Jarisch, A | 1 |
| Meerpohl, J | 1 |
| Strauss, G | 1 |
| Krysiak, R | 1 |
| Kobielusz-Gembala, I | 1 |
| Okopien, B | 1 |
| Annagür, A | 1 |
| Altunhan, H | 1 |
| Yüksekkaya, HA | 1 |
| Örs, R | 1 |
| Sutor, GC | 1 |
| Ceconi, C | 1 |
| Flemming, P | 1 |
| Wysk, J | 1 |
| Fabel, H | 1 |
| Schuppert, F | 1 |
| Muckenthaler, M | 1 |
| Richter, A | 1 |
| Gunkel, N | 1 |
| Riedel, D | 1 |
| Polycarpou-Schwarz, M | 1 |
| Hentze, S | 1 |
| Falkenhahn, M | 1 |
| Stremmel, W | 3 |
| Ansorge, W | 1 |
| Hentze, MW | 1 |
| NIELSEN, JB | 1 |
| NORDOY, A | 1 |
| BJORNSTAD, P | 1 |
| HJORT, PF | 1 |
| HEILMEYER, L | 2 |
| WOEHLER, F | 4 |
| JULIEN, C | 1 |
| LEMONNIER, F | 1 |
| ETIENNE, G | 1 |
| RUBMANN, A | 1 |
| CAROLI, J | 1 |
| VACHON, A | 3 |
| PALIARD, P | 2 |
| TETE, R | 2 |
| GYLLENSWAERD, A | 1 |
| ESTBORN, B | 1 |
| WALSH, JR | 4 |
| MASS, RE | 3 |
| SMITH, FW | 2 |
| LANGE, V | 2 |
| SAUNDERS, SJ | 1 |
| JIMENEZDIAZ, C | 1 |
| PERIANES, J | 1 |
| PELAEZ, JL | 1 |
| SANCHEZVILLARES, E | 1 |
| LINAZASORO, JM | 1 |
| VILLALOBOS, E | 1 |
| PESTEL, M | 1 |
| MARCACCI, M | 1 |
| CICALA, P | 1 |
| GUIDONE, M | 1 |
| NAPPI, L | 1 |
| DIMARTINO, G | 1 |
| ANGELINO, PF | 1 |
| FERRO, GF | 1 |
| VACCA, G | 1 |
| MEDICI, L | 1 |
| BUTLER, M | 1 |
| DARNAUD, C | 1 |
| DENARD, Y | 1 |
| VOISIN, R | 1 |
| LEMOZY, J | 1 |
| CARLOS, AG | 1 |
| SOARES, AD | 1 |
| TUTIN, M | 1 |
| TRINCAO, M | 1 |
| SERRAESILVA, P | 1 |
| SCURO, LA | 1 |
| BROCCIA, G | 1 |
| DOBRILLA, G | 2 |
| TAGLIAMONTE, A | 1 |
| ROMANO, C | 1 |
| MASSIMO, L | 1 |
| TORTOROLO, G | 1 |
| UNSELD, DW | 1 |
| VENTURA, S | 2 |
| BETTI, R | 1 |
| PALUMBO, R | 1 |
| SENIN, U | 1 |
| CAPPELLETTI, M | 1 |
| COLI, L | 2 |
| KAEMMERER, I | 1 |
| GERHARTZ, H | 1 |
| MOESCHLIN, S | 2 |
| SCHNIDER, U | 1 |
| WEILL, JP | 1 |
| SCHIRARDIN, H | 1 |
| ARBOGAST, J | 1 |
| BERTHIER, G | 1 |
| CAHILL, M | 2 |
| FOUET, P | 1 |
| CONTE, M | 1 |
| BODIN, F | 1 |
| ALBAHARY, C | 1 |
| VERHAEGEN-DECLERCQ, ML | 1 |
| VERHAEGEN, H | 1 |
| DE GROOT, EJ | 1 |
| FIELDING, J | 3 |
| BANNERMAN, RM | 2 |
| MALPAS, JS | 2 |
| CHANTRAINE, JM | 1 |
| KNOBLAUCH, M | 1 |
| WHITE, HC | 1 |
| CARVALHONETO, E | 1 |
| SCHNACK, H | 2 |
| WEWALKA, F | 2 |
| TEUBNER, K | 1 |
| WEISE, HJ | 1 |
| NEIMANN, N | 1 |
| PIERSON, M | 1 |
| MANCIAUX, M | 1 |
| VERT, P | 1 |
| SCHAACK, JC | 1 |
| CORMIER, J | 1 |
| PICHOT, J | 1 |
| DORCHE, J | 1 |
| PERROT, L | 1 |
| BIEDERMANN, P | 1 |
| FITZGERALD, JD | 1 |
| KEBERLE, H | 1 |
| SCHMID, JR | 2 |
| OECHSLIN, RJ | 2 |
| SCHNIDER, T | 1 |
| RISSEL, E | 2 |
| Nielsen, P | 1 |
| Fischer, R | 1 |
| Buggisch, P | 1 |
| Janka-Schaub, G | 1 |
| Sanchez, CR | 1 |
| Murray, S | 1 |
| Montali, RJ | 1 |
| Riva, A | 1 |
| Mariani, R | 1 |
| Bovo, G | 1 |
| Pelucchi, S | 1 |
| Arosio, C | 1 |
| Salvioni, A | 1 |
| Vergani, A | 1 |
| Piperno, A | 2 |
| Tilbrook, L | 1 |
| Berndt, A | 1 |
| Helwig, A | 1 |
| Ehninger, G | 1 |
| Bornhäuser, M | 1 |
| Jambrik, Z | 1 |
| Derchi, G | 1 |
| Picano, E | 1 |
| Ait-Ali, L | 1 |
| Forni, G | 1 |
| Bellotti, P | 1 |
| Kontoghiorghes, GJ | 2 |
| Eracleous, E | 1 |
| Economides, C | 1 |
| Kolnagou, A | 1 |
| Niederau, C | 3 |
| Polo-Romero, FJ | 1 |
| Fabio, G | 1 |
| Minonzio, F | 1 |
| Delbini, P | 1 |
| Bianchi, A | 1 |
| Cappellini, MD | 1 |
| Venkat-Raman, N | 1 |
| Venkata-Krishnan, RV | 1 |
| Howarth, ES | 1 |
| Templin, C | 1 |
| Pertschy, S | 1 |
| Schaefer, A | 1 |
| Keijzer, A | 1 |
| van der Valk, P | 1 |
| Ossenkoppele, GJ | 1 |
| van de Loosdrecht, AA | 1 |
| Ambrus, CM | 1 |
| Stadler, I | 1 |
| Toumbis, CA | 1 |
| Stadler, A | 1 |
| Anthone, S | 1 |
| Anthone, R | 1 |
| DeAlarcon, P | 1 |
| Deshpande, G | 1 |
| Conway, J | 1 |
| Vladutiu, AO | 1 |
| Ambrus, JL | 1 |
| Heffron, T | 1 |
| Pillen, T | 1 |
| Welch, D | 1 |
| Asolati, M | 1 |
| Smallwood, G | 1 |
| Hagedorn, P | 1 |
| Fasola, C | 1 |
| Solis, D | 1 |
| Rodrigues, J | 1 |
| DePaolo, J | 1 |
| Spivey, J | 1 |
| Martinez, E | 1 |
| Henry, S | 1 |
| Romero, R | 1 |
| Buffet, C | 1 |
| Janower, S | 1 |
| Rosmorduc, O | 1 |
| Cohen, A | 2 |
| Nick, H | 1 |
| Kefala-Agoropoulou, K | 1 |
| Roilides, E | 1 |
| Lazaridou, A | 1 |
| Karatza, E | 1 |
| Farmaki, E | 1 |
| Tsantali, H | 1 |
| Augoustides-Savvopoulou, P | 1 |
| Tsiouris, J | 1 |
| Krayenbühl, P | 1 |
| Naumann, UK | 1 |
| Käser, L | 1 |
| Vetter, W | 1 |
| Park, SJ | 1 |
| Han, CW | 1 |
| Beurey, J | 1 |
| Weber, M | 1 |
| Montet, Y | 1 |
| Jeandidier, P | 1 |
| Barbier, JM | 1 |
| Strohmeyer, G | 6 |
| Keusch, G | 1 |
| Kreimer-Birnbaum, M | 1 |
| Vance, VK | 1 |
| Vaughan, S | 1 |
| Thompson, RB | 1 |
| Owen, DM | 1 |
| Bell, WN | 1 |
| Wöhler, F | 3 |
| Williams, R | 3 |
| Dowzenko, A | 1 |
| Marecik-Piasecka, G | 1 |
| Palynyczko, Z | 1 |
| Witzleben, C | 1 |
| Schwartz, E | 1 |
| Propper, R | 1 |
| Nathan, D | 1 |
| Gollan, JL | 1 |
| McLaren, GD | 1 |
| Muir, WA | 1 |
| Kellermeyer, RW | 1 |
| Kol'tsova, GN | 1 |
| Mel'nikovskaia, NN | 1 |
| Likhodzievskiĭ, KG | 1 |
| Rozenberg, GIa | 1 |
| Roeser, HP | 1 |
| Baudouy, P | 1 |
| Lombrail, P | 1 |
| Azancot, I | 1 |
| Piekarski, A | 1 |
| Martin, E | 1 |
| Slama, R | 1 |
| Conte, D | 2 |
| Brunelli, L | 1 |
| Ferrario, L | 1 |
| Mandelli, C | 2 |
| Quatrini, M | 1 |
| Velio, P | 1 |
| Bianchi, PA | 2 |
| Volkholz, HJ | 1 |
| Sailer, D | 1 |
| Rödl, W | 1 |
| Van der Weyden, MB | 2 |
| Schmidt, U | 1 |
| Preu, E | 1 |
| Tuschy, U | 1 |
| Senf, L | 1 |
| Herre, K | 1 |
| Delvaux, D | 1 |
| Andrien, JM | 1 |
| Fillet, G | 1 |
| Huebers, H | 1 |
| Palmas, S | 1 |
| Brown, EB | 2 |
| Simon, M | 7 |
| Hespel, JP | 1 |
| Brissot, P | 3 |
| Fauchet, R | 1 |
| Edan, G | 1 |
| Le Reun, M | 1 |
| Le Mignon, L | 3 |
| Genetet, B | 1 |
| Bourel, M | 6 |
| Bottomley, SS | 1 |
| Smithson, WA | 1 |
| Perrault, J | 1 |
| Fargion, S | 2 |
| Taddei, MT | 1 |
| Gabutti, V | 1 |
| Piga, A | 1 |
| Di Palma, A | 1 |
| Capra, L | 1 |
| Fontanelli, G | 1 |
| Avanzini, A | 1 |
| Simon, P | 2 |
| Bonn, F | 1 |
| Guezennec, M | 1 |
| Tanquerel, T | 1 |
| Salem, HH | 1 |
| Firkin, BG | 1 |
| Halliday, JW | 2 |
| Bassett, ML | 2 |
| Herry, D | 1 |
| Verger, JP | 1 |
| Messner, M | 1 |
| Beaumont, C | 1 |
| Regnouard, F | 1 |
| Ferrand, B | 1 |
| Locasciulli, A | 1 |
| Monguzzi, W | 1 |
| Tornotti, G | 1 |
| Bianco, P | 1 |
| Masera, G | 1 |
| Politi, A | 1 |
| Sticca, M | 1 |
| Galli, M | 1 |
| Lewinski, UH | 1 |
| Floru, S | 1 |
| Cohen, AM | 1 |
| Mittelmann, M | 1 |
| Levina, AA | 1 |
| Tsvetaeva, NV | 1 |
| Minaeva, LM | 1 |
| Tsibul'skaia, MM | 1 |
| Shcherbinina, SP | 1 |
| Zavadenko, MA | 1 |
| Meshcheriakova, LM | 1 |
| Tokarev, IuN | 1 |
| Wang, TL | 1 |
| Chen, WJ | 1 |
| Liau, CS | 1 |
| Lee, YT | 1 |
| Jaulmes, D | 1 |
| Quarre, MC | 1 |
| Audat, F | 1 |
| Gaonach, MJ | 1 |
| Cutler, P | 2 |
| Blei, F | 1 |
| Puder, DR | 1 |
| Jensen, PD | 1 |
| Bagger, JP | 1 |
| Jensen, FT | 1 |
| Baandrup, U | 1 |
| Christensen, T | 1 |
| Ellegaard, J | 1 |
| Giardini, C | 2 |
| La Nasa, G | 1 |
| Contu, L | 1 |
| Galimberti, M | 2 |
| Polchi, P | 2 |
| Angelucci, E | 2 |
| Baronciani, D | 2 |
| Barbanti, I | 1 |
| Muretto, P | 2 |
| Lucarelli, G | 2 |
| Martinelli, F | 1 |
| Baldassarri, M | 1 |
| Oerter, KE | 1 |
| Kamp, GA | 1 |
| Munson, PJ | 1 |
| Nienhuis, AW | 2 |
| Cassorla, FG | 1 |
| Manasco, PK | 1 |
| Held, JL | 1 |
| Yankiver, B | 1 |
| Kohn, SR | 1 |
| Giardina, PJ | 1 |
| Grady, RW | 3 |
| Lombardo, T | 1 |
| Ferro, G | 1 |
| Frontini, V | 1 |
| Percolla, S | 1 |
| Paolo, C | 1 |
| Francesco, S | 1 |
| Sergio, A | 1 |
| Swartz, RD | 1 |
| Legault, DJ | 1 |
| Güngör, T | 1 |
| Rohrbach, E | 1 |
| Solem, E | 1 |
| Kaltwasser, JP | 1 |
| Kornhuber, B | 1 |
| Kobayashi, M | 1 |
| Yano, K | 1 |
| Fujisawa, S | 1 |
| Spraul, CW | 1 |
| Schicketanz, C | 1 |
| Lang, GE | 1 |
| Cianciulli, P | 1 |
| Sorrentino, F | 1 |
| Maffei, L | 1 |
| Amadori, S | 1 |
| Madani, TA | 1 |
| Bormanis, J | 1 |
| Jurado, RL | 1 |
| Aul, C | 1 |
| Gattermann, N | 1 |
| Jaeger, M | 1 |
| Sigurdsson, L | 1 |
| Reyes, J | 1 |
| Kocoshis, SA | 1 |
| Hansen, TW | 1 |
| Rosh, J | 1 |
| Knisely, AS | 1 |
| Kelly, AL | 1 |
| Rhodes, DA | 1 |
| Roland, JM | 1 |
| Schofield, P | 1 |
| Cox, TM | 2 |
| Herbert, V | 1 |
| De Gobbi, M | 1 |
| Pasquero, P | 1 |
| Brunello, F | 1 |
| Paccotti, P | 1 |
| Mazza, U | 1 |
| Camaschella, C | 1 |
| Pippard, MJ | 1 |
| Letsky, EA | 1 |
| Callender, ST | 1 |
| Weatherall, DJ | 2 |
| Powell, LW | 1 |
| O'Brien, RT | 1 |
| Bothwell, TH | 2 |
| Charlton, RW | 2 |
| Modell, B | 1 |
| Graziano, JH | 2 |
| Fehr, J | 1 |
| Zuppinger, K | 1 |
| Molinari, B | 1 |
| Hirt, A | 1 |
| Imbach, P | 1 |
| Gugler, E | 1 |
| Tönz, O | 1 |
| Zurbrügg, RP | 1 |
| M'Seffar, A | 1 |
| Fornasier, VL | 1 |
| Fox, IH | 1 |
| Baldus, WP | 1 |
| Fairbanks, VF | 1 |
| Dickson, ER | 1 |
| Baggenstoss, AH | 1 |
| Olsson, KS | 2 |
| Heedman, PA | 1 |
| Staugárd, F | 1 |
| Blume, KG | 1 |
| Beutler, E | 1 |
| Chillar, RK | 1 |
| Fahey, JL | 1 |
| Sharkoff, D | 1 |
| Zia, PK | 1 |
| Cartei, G | 3 |
| Cazzavillan, M | 1 |
| Chisesi, T | 1 |
| Battista, R | 1 |
| Barbui, T | 1 |
| Dini, E | 1 |
| Young, N | 1 |
| Henry, W | 1 |
| Walters, GO | 1 |
| Jacobs, A | 1 |
| Worwood, M | 1 |
| Trevett, D | 1 |
| Thomson, W | 1 |
| Hershko, C | 4 |
| Alexandre, JL | 1 |
| Le Marec, B | 1 |
| Scordia, C | 1 |
| Sinclair, WP | 1 |
| Afrooz, N | 1 |
| Edwards, CQ | 1 |
| Carroll, M | 1 |
| Bray, P | 1 |
| Cartwright, GE | 1 |
| Miller, A | 1 |
| Zimelman, A | 1 |
| Brauer, MJ | 1 |
| Kaszewska-Jablońska, I | 1 |
| Zielińska, W | 1 |
| Kautzsch, E | 1 |
| Florence, A | 1 |
| Ward, RJ | 2 |
| Peters, TJ | 2 |
| Crichton, RR | 1 |
| Sugie, Y | 1 |
| Tsuji, H | 1 |
| Nomiyama, K | 1 |
| Ishitsuka, T | 1 |
| Akagi, K | 1 |
| Fujishima, M | 1 |
| Shibuya, T | 1 |
| Okamura, T | 1 |
| Kubota, K | 1 |
| Kurabayashi, H | 1 |
| Tamura, J | 1 |
| Kawada, E | 1 |
| Tamura, K | 1 |
| Nagashima, K | 1 |
| Shirakura, T | 1 |
| de Montalembert, M | 2 |
| Jan, D | 1 |
| Clairicia, M | 1 |
| Hannedouche, T | 2 |
| Sidi, D | 1 |
| Girot, R | 3 |
| Chandy, M | 1 |
| Nouel, O | 1 |
| Voisin, PM | 1 |
| Vaucel, J | 1 |
| Dartois-Hoguin, M | 1 |
| Le Bris, M | 1 |
| Valenkevich, LN | 1 |
| Iakhontova, OI | 1 |
| de Sousa, M | 1 |
| Reimão, R | 1 |
| Porto, G | 1 |
| Hilgartner, MW | 1 |
| Giardina, P | 1 |
| Cecchetti, G | 1 |
| Binda, A | 1 |
| Nador, F | 1 |
| Fiorelli, G | 1 |
| Scieszka, J | 1 |
| Kalina, Z | 1 |
| Knap, J | 1 |
| Lehmann, WD | 1 |
| Heinrich, HC | 1 |
| Pinson, A | 2 |
| Link, G | 2 |
| Amendola, G | 1 |
| Garvin, J | 1 |
| Piomelli, S | 1 |
| Bonkovsky, HL | 1 |
| Weber, R | 1 |
| Aaron, L | 1 |
| Emami, A | 1 |
| Fagundus, DM | 1 |
| Grootveld, M | 1 |
| Bell, JD | 1 |
| Halliwell, B | 1 |
| Aruoma, OI | 1 |
| Bomford, A | 2 |
| Sadler, PJ | 1 |
| Borecki, IB | 1 |
| Rao, DC | 1 |
| Yaouanq, J | 1 |
| Lalouel, JM | 1 |
| Schneider, C | 1 |
| Richter, H | 1 |
| Fischer, JL | 1 |
| Larcher, W | 1 |
| Llados, A | 1 |
| Llados i Vallory, EA | 1 |
| Lenoir, G | 1 |
| Payet, M | 1 |
| Houze, P | 1 |
| Bourdon, R | 1 |
| O'Connell, MJ | 1 |
| Dickson, DP | 1 |
| Reid, NM | 1 |
| Wade, VJ | 1 |
| Mann, S | 1 |
| Cesana, M | 1 |
| Tiribelli, C | 1 |
| Eijgenraam, FJ | 1 |
| Donckerwolcke, RA | 1 |
| van Dijken, PJ | 1 |
| Säfwenberg, J | 1 |
| Ritter, B | 1 |
| Nagamachi, S | 1 |
| Hoshi, H | 1 |
| Jinnouchi, S | 1 |
| Ono, S | 1 |
| Watanabe, K | 1 |
| Allain, P | 1 |
| Mauras, Y | 1 |
| Chaleil, D | 1 |
| Ang, KS | 1 |
| Cam, G | 1 |
| Hakim, RM | 1 |
| Stivelman, JC | 1 |
| Schulman, G | 1 |
| Fosburg, M | 1 |
| Wolfe, L | 1 |
| Imber, MJ | 1 |
| Lazarus, JM | 1 |
| Cumming, RL | 2 |
| Goldberg, A | 2 |
| Morrow, J | 1 |
| Smith, JA | 2 |
| Smith, PM | 1 |
| Studley, F | 1 |
| MacDonald, RA | 1 |
| MacSween, RN | 1 |
| Pechet, GS | 1 |
| Bohne, F | 2 |
| Harmuth-Hoene, AE | 1 |
| Weber, KM | 1 |
| Lenoir, P | 1 |
| Allannic, H | 1 |
| Chauvel, A | 1 |
| Danon, G | 1 |
| Etienne, JP | 1 |
| Passa, P | 1 |
| Cerami, A | 1 |
| Giorgio, AJ | 1 |
| de Haan, BB | 1 |
| Scherrer, JR | 1 |
| Stauffacher, W | 1 |
| Pometta, D | 1 |
| Stich, W | 1 |
| Brodanová, M | 1 |
| Bednár, D | 1 |
| Sakić, D | 1 |
| Zlatar, P | 1 |
| Saddi, R | 1 |
| Feingold, J | 1 |
| Stromeyer, G | 1 |
| Dyerberg, J | 2 |
| Turbina, NS | 1 |
| Stacher, A | 1 |
| Dökert, B | 1 |
| Schwenke, R | 1 |
| Ghidoni, A | 2 |
| Sanesi, E | 1 |
| Pozza, G | 2 |
| Pergola, F | 1 |
| Michaelis, D | 2 |
| Takác, A | 2 |
| Bruns, W | 2 |
| Waxman, HS | 1 |
| Apollonova, LA | 1 |
| Phlippen, R | 1 |
| Najean, Y | 1 |
| Dresch, C | 1 |
| Darnis, F | 1 |
| Mossé, A | 1 |
| Breauté, C | 1 |
| Delorme, ML | 1 |
| Hahn, A | 2 |
| Keler-Bacoka, M | 2 |
| Hedenberg, L | 1 |
| Singh, AK | 1 |
| Bianco, G | 1 |
| Gallo, E | 1 |
| Ramello, A | 1 |
| Ricco, G | 1 |
| Matone, S | 1 |
| Wapnick, AA | 1 |
| Lynch, SR | 1 |
| Seftel, HC | 1 |
| Barry, M | 1 |
| Sherlock, S | 1 |
| Gerlanc, MD | 1 |
| Zapolski, EJ | 1 |
| Rubin, M | 1 |
| Princiotto, JV | 1 |
| Tsujimoto, T | 1 |
| Mitsutani, N | 1 |
| Nagatomo, T | 1 |
| Santiago Corchado, M | 1 |
| Ribas Ozonas, B | 1 |
| Dymock, IW | 1 |
| Miller, JP | 1 |
| Godfrey, BE | 1 |
| Nowotny, P | 1 |
| Böttger, G | 1 |
| Bennike, T | 1 |
| Delaloye, B | 1 |
| Magnenat, P | 1 |
| Blanc, B | 2 |
| Scandellari, C | 1 |
| Bosello, O | 1 |
| Cavallini, G | 1 |
| Lo Cascio, V | 1 |
| Miolin, A | 1 |
| Radojicić, B | 1 |
| Harker, LA | 1 |
| Funk, DD | 1 |
| Finch, CA | 1 |
| Fainshtein, FE | 1 |
| Trubina, NS | 1 |
| Sobaleva, IuG | 1 |
| Rozanova, NS | 1 |
| Voronina, AN | 1 |
| Jonker-Wuite, PG | 1 |
| Millar, JA | 1 |
| Lessmann, J | 1 |
| Giraud, P | 1 |
| Orsini, A | 1 |
| Giraud, F | 1 |
| Pinsard, N | 1 |
| Muranda, M | 1 |
| Velasco, M | 1 |
| Giménez, E | 1 |
| Ruiz, J | 1 |
| Bastías, E | 1 |
| Rodriguez, J | 1 |
| Etcheverry, R | 1 |
| Guzmán, C | 1 |
| Regonesi, C | 1 |
| Janklevich, S | 1 |
| Gillick, JB | 1 |
| Pokora, J | 1 |
| Matuszewski, M | 1 |
| Sliwińska, J | 1 |
| Moretti, G | 1 |
| Staeffen, J | 1 |
| Galley, P | 1 |
| Mulet, M | 1 |
| Descamps, F | 1 |
| Plachecka-Gutowska, M | 1 |
| Mikolajew, M | 1 |
| Kallee, E | 1 |
| Lohss, F | 1 |
| Debiasi, S | 1 |
| O'Shaughnessy, MC | 1 |
| Brunström, GM | 1 |
| Losowsky, MS | 1 |
| Ploem, JE | 1 |
| de Wael, J | 1 |
| Verloop, MC | 1 |
| Punt, K | 1 |
| Rosen, BJ | 1 |
| Tullis, JL | 1 |
| Vannotti, A | 1 |
| Lawecki, J | 1 |
| Rogala, H | 1 |
| Aron, E | 1 |
| Weill, JD | 1 |
| Galand, A | 1 |
| Mühler, E | 1 |
| Kirimlidis, S | 1 |
| Philippidis, P | 1 |
| Drossos, C | 1 |
| Economidis, J | 1 |
| Langsch, HG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot, Pharmacodynamic Correlate Trial of Sirolimus in Combination With Chemotherapy (Idarubicin, Cytarabine) for the Treatment of Newly Diagnosed Acute Myelogenous Leukemia[NCT01822015] | Early Phase 1 | 55 participants (Actual) | Interventional | 2013-03-15 | Completed | ||
| A Trial of Oral Nifedipine for the Treatment of Iron Overload[NCT00712738] | Phase 1 | 6 participants (Actual) | Interventional | 2008-06-20 | Completed | ||
| Double-blind, Randomized, Placebo Controlled, Dose-finding Phase 2 Clinical Trial of Intravenous Deferoxamine in Patients With Acute Ischemic Stroke Treated With Tissue Plasminogen Activator[NCT00777140] | Phase 2 | 62 participants (Actual) | Interventional | 2008-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
38 reviews available for deferoxamine and Bronze Diabetes
| Article | Year |
|---|---|
How I treat hemochromatosis.
Topics: Blood Donors; Chelation Therapy; Cytapheresis; Deferoxamine; Female; Hemochromatosis; Hemochromatosi | 2010 |
[HEMOCHROMATOSIS].
Topics: Bloodletting; Deferoxamine; Diagnosis; Dimercaprol; Drug Therapy; Edetic Acid; Hemochromatosis; Huma | 1964 |
Advances in iron overload therapies. prospects for effective use of deferiprone (L1), deferoxamine, the new experimental chelators ICL670, GT56-252, L1NA11 and their combinations.
Topics: Benzoates; Carboxylic Acids; Deferasirox; Deferiprone; Deferoxamine; Drug Therapy, Combination; Hemo | 2005 |
Future chelation monotherapy and combination therapy strategies in thalassemia and other conditions. comparison of deferiprone, deferoxamine, ICL670, GT56-252, L1NAll and starch deferoxamine polymers.
Topics: Benzoates; Carboxylic Acids; Chelation Therapy; Clinical Trials as Topic; Deferasirox; Deferiprone; | 2006 |
Chelation therapy for iron overload.
Topics: Anemia; Anemia, Sickle Cell; Benzoates; beta-Thalassemia; Chelation Therapy; Deferasirox; Deferipron | 2007 |
[Cardiac involvement in hemochromatosis].
Topics: Algorithms; Chelating Agents; Deferoxamine; Diagnosis, Differential; Dilatation, Pathologic; Echocar | 2007 |
Iron chelation, quo vadis?
Topics: Administration, Oral; Biological Transport; Deferoxamine; Hemochromatosis; Humans; Ions; Iron Chelat | 2007 |
[Hemochromatosis (hereditary, "primary" hemochromatosis)].
Topics: Adult; Age Factors; Biopsy; Deferoxamine; Diagnosis, Differential; Female; Genotype; Hemochromatosis | 2007 |
Treatment of iron overload.
Topics: Bloodletting; Carcinoma, Hepatocellular; Deferoxamine; Hemochromatosis; Humans; Liver; Liver Cirrhos | 1984 |
Clinical removal of iron.
Topics: Adult; Anemia, Sideroblastic; Bloodletting; Carcinoma, Hepatocellular; Deferoxamine; Diet; Erythropo | 1982 |
Diagnosis of hemochromatosis.
Topics: Biopsy; Deferoxamine; Diet; Ferritins; Hemochromatosis; Humans; Iron; Liver; Liver Function Tests; T | 1983 |
Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy.
Topics: Anemia, Hypochromic; Biological Transport; Bloodletting; Chelating Agents; Deferoxamine; Disease Mod | 1983 |
[Biologically active hydroxamic acids--iron complexons].
Topics: Animals; Chelating Agents; Chemical Phenomena; Chemistry; Deferoxamine; Hemochromatosis; Hemosideros | 1984 |
The role of ascorbic acid in the turnover of storage iron.
Topics: Adult; Animals; Ascorbic Acid; Deferoxamine; Ferritins; Guinea Pigs; Haplorhini; Hemochromatosis; He | 1983 |
[Physiopathology, diagnosis and therapy of hemochromatosis].
Topics: Biological Availability; Biological Transport; Bloodletting; Cardiovascular System; Chelating Agents | 1980 |
Recognition and treatment of iron overload.
Topics: Adult; Blood Grouping and Crossmatching; Bloodletting; Costs and Cost Analysis; Deferoxamine; Ethyle | 1980 |
[Hemochromatosis].
Topics: Alleles; Biopsy; Bloodletting; Bone Marrow Examination; Chelating Agents; Deferoxamine; Diet; Genes, | 1981 |
Sideroblastic anaemia.
Topics: 5-Aminolevulinate Synthetase; Adult; Anemia, Sideroblastic; Blood Transfusion; Bone Marrow; Chloramp | 1982 |
Yersinia enterocolitica bacteremia in a chronically transfused patient with sickle cell anemia. Case report and review of the literature.
Topics: Adolescent; Anemia, Sickle Cell; Bacteremia; Blood Transfusion; Ceftriaxone; Deferoxamine; Disease S | 1993 |
Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.
Topics: Adolescent; Adult; Chelating Agents; Chelation Therapy; Child; Deferoxamine; Growth Disorders; Heari | 1995 |
Iron, infections, and anemia of inflammation.
Topics: Anemia; Bacteria; Bacterial Infections; Blood Transfusion; Carrier Proteins; Conalbumin; Deferoxamin | 1997 |
Iron overload: clinical and pathologic aspects in pediatrics.
Topics: Abnormalities, Multiple; Adolescent; Adult; Ascorbic Acid Deficiency; Bloodletting; Child; Child, Pr | 1977 |
[Iron storage disorders].
Topics: Arrhythmias, Cardiac; Bloodletting; Deferoxamine; Diabetes Complications; Ferritins; Follicle Stimul | 1978 |
[Idiopathic haemochromatosis. I. Clinical, biological and therapeutic aspects (author's transl)].
Topics: Bloodletting; Bone Diseases; Cardiomyopathies; Deferoxamine; Diabetes Mellitus; Female; Ferritins; H | 1979 |
Current problems of iron overload.
Topics: Deferoxamine; Diet; Hemochromatosis; Humans; Iron; Thalassemia; Tissue Distribution | 1979 |
Advances in the use of iron-chelating agents for the treatment of iron overload.
Topics: Adolescent; Adult; Anemia; Child; Child, Preschool; Deferoxamine; Female; Ferritins; Heart; Hemochro | 1979 |
Iron metabolism and chelation therapy in hemosiderosis.
Topics: Ascorbic Acid; Blood Transfusion; Chelating Agents; Deferoxamine; Diet; Gentisates; Hemochromatosis; | 1978 |
Iron and lymphocytes: reciprocal regulatory interactions.
Topics: Animals; Bloodletting; CD4-CD8 Ratio; Chelation Therapy; Deferoxamine; Ferric Compounds; Hemochromat | 1991 |
[Hemochromatosis of the heart].
Topics: Cardiomyopathies; Deferoxamine; Hemochromatosis; Humans; Iron; Myocardium | 1990 |
Iron chelation.
Topics: Administration, Oral; Chelation Therapy; Deferoxamine; Drug Design; Drug Evaluation; Free Radicals; | 1990 |
Haemochromatosis.
Topics: Bloodletting; Carrier Proteins; Deferoxamine; Genetic Markers; Hemochromatosis; Humans; Iron | 1990 |
Iron-chelating therapy.
Topics: Animals; Ascorbic Acid; Deferoxamine; Hemochromatosis; Humans; Iron; Iron Chelating Agents | 1988 |
Deferoxamine in measurement of iron stores.
Topics: Animals; Deferoxamine; Hemochromatosis; Hemosiderosis; Humans; Iron; Rats | 1968 |
[Deferoxamine-B, a ferriuretic chelate].
Topics: Anemia, Hypochromic; Chemical Phenomena; Chemistry; Deferoxamine; Hemochromatosis; Hemosiderosis; Hu | 1967 |
[Use of desferal in treatment of sideroses of different origin. (Literature review)].
Topics: Anemia; Anemia, Aplastic; Anemia, Sideroblastic; Animals; Bile; Child, Preschool; Deferoxamine; Hemo | 1968 |
[Diseases caused by iron metabolism disorders and their therapy].
Topics: Adult; Anemia, Hypochromic; Anti-Glomerular Basement Membrane Disease; Bloodletting; Deferoxamine; D | 1969 |
[Pathogenesis, clinical aspects and therapy of siderophilia (hemochromatosis)].
Topics: Bloodletting; Deferoxamine; Diagnosis, Differential; Diet Therapy; Hematologic Diseases; Hemochromat | 1971 |
Clinical usefulness of iron chelating agents.
Topics: Chelating Agents; Deferoxamine; Dimercaprol; Edetic Acid; Hemochromatosis; Humans; Iron; Iron Chelat | 1969 |
243 other studies available for deferoxamine and Bronze Diabetes
| Article | Year |
|---|---|
New Deferric Amine Compounds Efficiently Chelate Excess Iron to Treat Iron Overload Disorders and to Prevent Ferroptosis.
Topics: Amines; Animals; Deferiprone; Deferoxamine; Dextrans; Ferroptosis; Hemochromatosis; Humans; Iron; Ir | 2022 |
Reversal of end-stage heart failure in juvenile hemochromatosis with iron chelation therapy: a case report.
Topics: Adult; Biopsy; Chelation Therapy; Deferoxamine; Echocardiography; Ferritins; Heart Failure; Heart Ve | 2018 |
Cardiac Hemochromatosis Treated With Prolonged Extracorporeal Membrane Oxygenation Support and Chelation Therapy.
Topics: Adult; Cardiomyopathies; Chelation Therapy; Deferasirox; Deferiprone; Deferoxamine; Extracorporeal M | 2018 |
Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents.
Topics: Adolescent; Adult; Child; Clioquinol; Deferoxamine; Erythrocytes; Female; Ferritins; Fibrin; Hemochr | 2014 |
Improvement in Left Ventricular Function Despite No Change in T2* with Iron Chelation in Secondary Hemochromatosis.
Topics: Adult; Anemia, Aplastic; Deferiprone; Deferoxamine; Echocardiography; Hemochromatosis; Humans; Iron | 2015 |
Successful Treatment of Iron-Overload Cardiomyopathy in Hereditary Hemochromatosis With Deferoxamine and Deferiprone.
Topics: Cardiomyopathies; Deferiprone; Deferoxamine; Ferritins; Heart Failure; Hemochromatosis; Hemochromato | 2016 |
Deferoxamine-related ocular toxicity: incidence and outcome in a pediatric population.
Topics: Child; Deferoxamine; Female; Hemochromatosis; Humans; Incidence; Iron Chelating Agents; Male; Monito | 2008 |
[Guidelines for diagnosis and treatment of secondary iron overload in patients with congenital anemia].
Topics: Anemia, Aplastic; Anemia, Diamond-Blackfan; Anemia, Dyserythropoietic, Congenital; Anemia, Sickle Ce | 2010 |
Recurrent pregnancy-induced diabetes insipidus in a woman with hemochromatosis.
Topics: Adult; Biopsy, Needle; Cystinyl Aminopeptidase; Deferoxamine; Diabetes Insipidus; Female; Hemochroma | 2010 |
Therapeutic management of neonatal hemochromatosis: report of four cases and literature review.
Topics: Acetylcysteine; Antioxidants; Deferoxamine; Female; Hemochromatosis; Humans; Infant, Newborn; Seleni | 2011 |
[An older female patient with refractory anemia and hemochromatosis].
Topics: Aged; Anemia, Sideroblastic; Colonic Polyps; Deferoxamine; Diagnosis, Differential; Female; Ferritin | 2002 |
Relationships and distinctions in iron-regulatory networks responding to interrelated signals.
Topics: Deferoxamine; DNA, Complementary; Ferric Compounds; Gene Expression Profiling; Gene Expression Regul | 2003 |
Influence of desferrioxamine on the renal excretion of iron. Preliminary report.
Topics: Deferoxamine; Hemochromatosis; Hydroxamic Acids; Iron; Leadership; Renal Elimination | 1963 |
[Desferrioxamine-B in hemochromatosis].
Topics: Chelating Agents; Deferoxamine; Hemochromatosis; Humans; Iron | 1963 |
[Modern problems of hemochromatosis with special reference to desferrioxamine treatment].
Topics: Deferoxamine; Hemochromatosis; Hydroxamic Acids; Iron | 1962 |
[Hemochromatosis and desferrioxamine. (Initial results apropos of 7 cases)].
Topics: Chelating Agents; Deferoxamine; Hemochromatosis; Hydroxamic Acids | 1963 |
THE TREATMENT OF HAEMOCHROMATOSIS WITH DESFERRIOXAMINE.
Topics: Anemia; Anemia, Macrocytic; Deferoxamine; Diabetes Mellitus; Ferritins; Hemochromatosis; Hemoglobins | 1963 |
[COURSE OF THE DIABETES OF HEMOCHROMATOSIS UNDER THE INFLUENCE OF BLOODLETTING AND THE BLOODLETTING-DESFERRIOXAMINE COMBINATION].
Topics: Bloodletting; Deferoxamine; Diabetes Mellitus; Hemochromatosis; Hydroxamic Acids | 1963 |
[HEMOCHROMATOSIS--A CASE TREATED WITH DESFERRIOXAMINE].
Topics: Body Fluids; Child; Deferoxamine; Hemochromatosis; Hydroxamic Acids; Iron Chelating Agents; Sweden; | 1963 |
DESFERRIOXAMINE EFFECT ON IRON EXCRETION IN HEMOCHROMATOSIS.
Topics: Deferoxamine; Hemochromatosis; Hemosiderosis; Humans; Iron; Iron Chelating Agents; Iron Isotopes; Le | 1964 |
IRON METABOLISM IN SYMPTOMATIC PORPHYRIA. A PRELIMINARY COMMUNICATION.
Topics: Alcoholism; Blood Chemical Analysis; Chelating Agents; Deferoxamine; Feces; Hemochromatosis; Hexachl | 1963 |
[FAMILIAL INFANTILE HEMOCHROMATOSIS].
Topics: Adolescent; Biopsy; Child; Clinical Laboratory Techniques; Deferoxamine; Genetics, Medical; Hemochro | 1963 |
[HEMOCHROMATOSIS].
Topics: Alcoholism; Biopsy; Blood Chemical Analysis; Bloodletting; Chelating Agents; Deferoxamine; Diabetes | 1964 |
[INFLUENCE OF DESFERRIOXAMINE ON THE URINARY ELIMINATION OF IRON IN NORMAL AND PATHOLOGICAL SUBJECTS].
Topics: Anemia; Deferoxamine; Duodenal Ulcer; Hemochromatosis; Humans; Hydroxamic Acids; Hypersplenism; Iron | 1964 |
[CHELATING TREATMENT OF HEMOCHROMATOSIS WITH DESFERRIOXAMINE BY MOUTH AND PARENTERAL ADMINISTRATION].
Topics: Chelating Agents; Deferoxamine; Gastrointestinal Tract; Hemochromatosis; Hemosiderin; Humans; Hydrox | 1964 |
IDIOPATHIC HEMOCHROMATOSIS.
Topics: Deferoxamine; Hemochromatosis; Humans; Iron Chelating Agents; Vascular Surgical Procedures | 1963 |
[DESFERRIOXAMINE IN THE TREATMENT OF HEMOCHROMATOSIS].
Topics: Chelating Agents; Deferoxamine; Diuresis; Gastric Mucosa; Hemochromatosis; Hepatomegaly; Humans; Liv | 1964 |
[THE USE OF DESFERRIOXAMINE IN THE TREATMENT OF HEMOCHROMATOSIS].
Topics: Anemia; Anemia, Aplastic; Blood Chemical Analysis; Body Fluids; Deferoxamine; Hemochromatosis; Hydro | 1964 |
[THE TREATMENT OF HEMOCHROMATOSIS].
Topics: Bloodletting; Chelating Agents; Deferoxamine; Diet; Diet Therapy; Dimercaprol; Edetic Acid; Hemochro | 1964 |
[HEPATIC UPTAKE OF RADIOACTIVE IRON BEFORE AND AFTER ADMINISTRATION OF DESFERRIOXAMINE IN HEMOCHROMATOSIS].
Topics: Deferoxamine; Hemochromatosis; Hydroxamic Acids; Iron; Iron Isotopes; Liver; Liver Function Tests; P | 1964 |
[A NEW TEST FOR ASCERTAINMENT OF STATES OF SIDEROSIS: THE DESFERRIOXAMINE TEST. PRELIMINARY RESULTS].
Topics: Anemia; Anemia, Hypochromic; Biomedical Research; Deferoxamine; Hematologic Diseases; Hemochromatosi | 1964 |
[PRELIMINARY NOTE ON THE THERAPEUTIC USE OF DESFERRIOXAMINE IN COOLEY'S DISEASE].
Topics: Blood Transfusion; Child; Deferoxamine; Hemochromatosis; Humans; Hydroxamic Acids; Infant; Iron; Tha | 1964 |
[A NEW TEST ("DESFERAL TEST") FOR THE DEMONSTRATION OF PATHOLOGICAL IRON DEPOSITS IN THE ORGANISM].
Topics: Deferoxamine; Diagnosis, Differential; Hemochromatosis; Hemosiderosis; Hepatitis; Hepatitis A; Human | 1964 |
[RESEARCH ON DESFERRIOXAMINE B. II. THE MECHANISM OF FERRO-CHELATION "IN VIVO" BY DESFERRIOXAMINE B].
Topics: Anemia; Anemia, Hypochromic; Deferoxamine; Erythrocytes; Hemochromatosis; Ions; Iron; Iron Isotopes; | 1964 |
[RESEARCH ON DESFERRIOXAMINE B. 3. THE CLINICAL USE OF DESFERRIOXAMINE B].
Topics: Anemia; Anemia, Hemolytic; Anemia, Macrocytic; Deferoxamine; Hematologic Diseases; Hemochromatosis; | 1964 |
THE TREATMENT OF HAEMOCHROMATOSIS WITH DESFERRIOXAMINE.
Topics: Deferoxamine; Drug Therapy; Hemochromatosis; Humans | 1964 |
TREATMENT OF PRIMARY AND SECONDARY HEMOCHROMATOSIS AND ACUTE IRON POISONING WITH A NEW POTENT IRON ELIMINATING AGENT (DESFERRIOXAMINE B-DFOM).
Topics: Anemia; Anemia, Aplastic; Anemia, Hemolytic; Anemia, Macrocytic; Deferoxamine; Guinea Pigs; Heavy Me | 1964 |
[SIDERURIA INDUCED BY A NEW CHELATING AGENT: DESFERRIOXAMINE].
Topics: Alcoholism; Chelating Agents; Deferoxamine; Hemochromatosis; Humans; Iron; Liver Cirrhosis; Toxicolo | 1964 |
HAEMOCHROMATOSIS, A BLOOD DYSCRASIA.
Topics: Clinical Laboratory Techniques; Deferoxamine; Diet; Diet, Reducing; Digoxin; Drug Therapy; Hematolog | 1964 |
MEDICAL ASPECTS OF HAEMOCHROMATOSIS.
Topics: Deferoxamine; Hemochromatosis; Humans | 1964 |
[TREATMENT OF HEMOCHROMATOSIS BY REPEATED BLEEDING AND DESFERROXAMINE].
Topics: Bloodletting; Coal Tar; Deferoxamine; Hemochromatosis; Hemorrhage; Humans; Therapeutics | 1964 |
[DESFERRIOXAMINE (DF) AND DIETHYLENE TRIAMINE PENTA-ACETIC ACID TRISODIUM CALCIUM SALT (CA DTPA NA3) IN SIDEROSIS. 2].
Topics: Anemia; Anemia, Hypochromic; Blood Transfusion; Calcium; Chelating Agents; Deferoxamine; Drug Therap | 1965 |
[TREATMENT OF HEMOCHROMATOSIS].
Topics: Deferoxamine; Drug Therapy; Hemochromatosis; Hemosiderosis; Humans; Porphyrias; Thalassemia | 1965 |
DIFFERENTIAL FERRIOXAMINE TEST FOR MEASURING CHELATABLE BODY IRON.
Topics: Anemia; Anemia, Aplastic; Anemia, Hemolytic; Anemia, Iron-Deficiency; Anemia, Pernicious; Deferoxami | 1965 |
STUDIES ON DESFERRIOXAMINE IN RELATION TO THE ABSORPTION OF IRON.
Topics: Anemia; Anemia, Hypochromic; Deferoxamine; Hemochromatosis; Hemoglobins; Intestinal Absorption; Iron | 1965 |
[TREATMENT OF SECONDARY HEMOCHROMATOSIS WITH DESFERRIOXAMINE B].
Topics: Child; Deferoxamine; Drug Therapy; Hemochromatosis; Humans; Infant; Thalassemia | 1964 |
[EFFECT OF DESFERRIOXAMINE ON LIVER SEGMENTS IN HEMOCHROMATOSIS].
Topics: Deferoxamine; Hematologic Tests; Hemochromatosis; Hemosiderin; Liver; Pathology | 1965 |
IRON LOADING ANEMIA.
Topics: Anemia; Anemia, Hypochromic; Bloodletting; Deferoxamine; Drug Therapy; Hemochromatosis; Humans; Iron | 1965 |
[SOMETHING NEW FOR THE TREATMENT OF SIDEROSIS].
Topics: Deferoxamine; Hemochromatosis; Humans; Siderosis | 1964 |
CHRONIC LIVER DISEASE AND IRON-STORAGE IN THE LIVER.
Topics: Deferoxamine; Hemochromatosis; Hepatitis; Hepatitis A; Humans; Iron; Liver Cirrhosis | 1964 |
[PATHOPHYSIOLOGY AND THERAPY OF HEMOCHROMATOSIS].
Topics: Adolescent; Child; Deferoxamine; Hemochromatosis; Humans; Liver Extracts | 1964 |
[THE EFFECT OF PHOSPHORUS AND CALCIUM SALTS AND IRON-POOR DIET OR IRON-FREE NUTRITION ON THE IRON EXCRETION BALANCE OF PATIENTS WITH HEMOCHROMATOSIS RECEIVING DESFERRIOXAMINE THERAPY].
Topics: Calcium; Calcium, Dietary; Deferoxamine; Diet; Hemochromatosis; Humans; Iron; Nutritional Status; Ph | 1964 |
[TREATMENT OF HEMOCHROMATOSIS CAUSED BY COOLEY'S ANEMIA BY DESFERRIOXAMINE. PRELIMINARY RESULTS].
Topics: beta-Thalassemia; Deferoxamine; Hemochromatosis; Humans; Thalassemia | 1965 |
[DISTANT FUTURE OF PIGMENTARY CIRRHOSIS FOLLOWING ELIMINATION OF THE IRON LOAD].
Topics: Biological Transport; Bloodletting; Deferoxamine; Hemochromatosis; Humans; Iron | 1965 |
[EMPLOYMENT OF INJECTABLE DESFERRIOXAMINE B IN IRON LOADING OF HEMOCHROMATOSIS].
Topics: Deferoxamine; Drug Therapy; Employment; Hemochromatosis; Humans; Iron | 1965 |
STUDIES IN THE DEVELOPMENT OF A SCREENING TEST OF IRON STORAGE DISEASE.
Topics: Deferoxamine; Fluids and Secretions; Hemochromatosis; Humans; Iron; Mass Screening; Pharmacology; Ur | 1965 |
[ASIMPLE 6 HOUR TEST WITH INTRAMUSCULAR DESFERRIOXAMINE-B (DESFERAL) FOR THE DIAGNOSIS OF HEMOCHROMATOSIS].
Topics: Body Fluids; Deferoxamine; Diagnosis; Hemochromatosis; Humans; Injections, Intramuscular; Urine | 1964 |
IRON CHELATION WITH DEFEROXAMINE IN HEPATIC DISEASE.
Topics: Ammonium Chloride; Biological Transport; Deferoxamine; Fluids and Secretions; Gene Expression Regula | 1965 |
[DESFERRIOXAMINE THERAPY IN LIVER DISEASES].
Topics: Deferoxamine; Drug Therapy; Hemochromatosis; Humans; Iron; Liver Diseases | 1964 |
[THE EFFECT OF DESFERRIOXAMINE-B (DESFERAL) ON THE PLASMA CLEARANCE OF FE 59 IN HEALTHY PERSONS AND PATIENTS WITH PRIMARY HEMOCHROMATOSIS].
Topics: Blood; Body Fluids; Deferoxamine; Hemochromatosis; Humans; Iron; Iron Isotopes; Pharmacology; Plasma | 1964 |
[ON THE TREATMENT OF HEPATIC SIDEROSIS].
Topics: Deferoxamine; Drug Therapy; Hemochromatosis; Hepatolenticular Degeneration; Humans; Liver Diseases; | 1964 |
Effective treatment of hereditary haemochromatosis with desferrioxamine in selected cases.
Topics: Deferoxamine; Female; Ferritins; Hemochromatosis; Humans; Iron; Liver; Male; Middle Aged; Treatment | 2003 |
Use of desferoxamine and S-adenosylmethionine to treat hemochromatosis in a red ruffed lemur (Varecia variegata ruber).
Topics: Animals; Blood Chemical Analysis; Combined Modality Therapy; Deferoxamine; Fatal Outcome; Hematologi | 2004 |
Type 3 hemochromatosis and beta-thalassemia trait.
Topics: Adult; Amino Acid Substitution; beta-Thalassemia; Biopsy; Cardiomyopathy, Dilated; Chelation Therapy | 2004 |
Cross talk between iron metabolism and diabetes.
Topics: Aged; Amino Acids; Arteriosclerosis; Chromium; Cytokines; Deferoxamine; Diabetes Mellitus; Diabetes | 2004 |
Successful transplantation of CD34+ selected peripheral blood stem cells from an unrelated donor in an adult patient with Diamond-Blackfan anemia and secondary hemochromatosis.
Topics: Adolescent; Alleles; Anemia, Diamond-Blackfan; Antigens, CD34; Deferoxamine; Drug Resistance; Echoca | 2005 |
Lack of prognostic value of normalized integrated backscatter analysis of myocardium in patients with thalassemia major: a long-term follow-up study.
Topics: Acoustics; Adolescent; Adult; beta-Thalassemia; Blood Transfusion; Cardiac Output, Low; Chelation Th | 2005 |
[Clinical findings and therapy of classical hereditary haemochromatosis (type 1)].
Topics: Benzoates; Deferasirox; Deferoxamine; Ferritins; Genes, MHC Class I; Genes, Recessive; Hemochromatos | 2005 |
Intramuscular deferoxamine in hereditary hemochromatosis.
Topics: Adult; Amino Acid Substitution; Deferoxamine; Female; Ferritins; Hemochromatosis; Hemochromatosis Pr | 2006 |
Reversal of cardiac complications by deferiprone and deferoxamine combination therapy in a patient affected by a severe type of juvenile hemochromatosis (JH).
Topics: Adult; Amino Acid Substitution; Antimicrobial Cationic Peptides; Atrial Fibrillation; Chelation Ther | 2007 |
Successful pregnancy outcome following maternal intravenous immunoglobulin treatment in a woman with recurrent perinatal haemochromatosis.
Topics: Acetylcysteine; Adult; Deferoxamine; Diagnosis, Differential; Female; Ferritins; Fetal Diseases; Fre | 2006 |
Cardiac hemochromatosis.
Topics: Deferoxamine; Erythrocyte Transfusion; Fatal Outcome; Female; Heart Diseases; Heart Failure; Hemochr | 2007 |
Mucormycosis in a patient with low risk myelodysplasia treated with anti-TNF-alpha.
Topics: Anemia, Refractory; Anemia, Sideroblastic; Antibodies, Monoclonal; Apoptosis; Combined Modality Ther | 2006 |
Removal of non-transferrin-bound iron from blood with iron overload using a device with immobilized desferrioxamine.
Topics: Anemia; Blood Transfusion; Chemical Fractionation; Child; Chromatography, Gel; Deferoxamine; Hemochr | 1999 |
Medical and surgical treatment of neonatal hemochromatosis: single center experience.
Topics: Antioxidants; Chelation Therapy; Deferoxamine; Disease Progression; Drug Therapy, Combination; Facto | 2007 |
[Hemochromatosis in the age of genetics].
Topics: Chelating Agents; Deferoxamine; Ferritins; Hemochromatosis; Hemochromatosis Protein; Histocompatibil | 2007 |
Pearson syndrome in an infant heterozygous for C282Y allele of HFE gene.
Topics: Anemia, Sideroblastic; Deferoxamine; Fatal Outcome; Female; Hemochromatosis; Hemochromatosis Protein | 2007 |
Complete hematopoietic recovery after continuous iron chelation therapy in a patient with severe aplastic anemia with secondary hemochromatosis.
Topics: Adolescent; Anemia, Aplastic; Chelation Therapy; Deferoxamine; Erythrocyte Transfusion; Hemochromato | 2008 |
[Porphyria cutanea tarda with hypersideremia: effectiveness of desferrioxamine (Desferal)].
Topics: Deferoxamine; Diagnosis, Differential; Hemochromatosis; Humans; Iron; Male; Middle Aged; Porphyrias | 1966 |
[Laboratory findings in hemochromatosis].
Topics: Chromium Isotopes; Deferoxamine; Diagnosis, Differential; Erythrocytes; Hemochromatosis; Humans; Inj | 1967 |
Thalassemia intermedia, with iron overload, cardiac failure, diabetes mellitus, hypopituitarism and porphyrinuria.
Topics: Adult; Blood Transfusion; Deferoxamine; Diabetes Mellitus; Folic Acid; Folic Acid Deficiency; Heart | 1967 |
Desferal therapy in iron storage disease.
Topics: Adolescent; Adult; Anemia, Aplastic; Anemia, Sickle Cell; Deferoxamine; Female; Hemochromatosis; Hem | 1967 |
Hypersiderosis.
Topics: Deferoxamine; Hemochromatosis; Hemosiderosis; Humans; Iron; Siderosis | 1967 |
[Therapeutic results in the treatment of primary and secondary hemochromatoses with Desferal].
Topics: Anemia, Macrocytic; Blood Transfusion; Deferoxamine; Hemochromatosis; Hemosiderosis; Humans; Injecti | 1967 |
Idiopathic hemochromatosis. II. Diagnosis and treatment.
Topics: Deferoxamine; Hemochromatosis; Hemosiderin; Humans; Iron; Iron Chelating Agents; Liver Cirrhosis | 1967 |
[On hydroxamic acid-iron compounds].
Topics: Absorption; Animals; Deferoxamine; Hemochromatosis; Humans; Hydrogen-Ion Concentration; Hydroxamic A | 1967 |
Cirrhosis with secondary siderosis or primary haemochromatosis.
Topics: Alcoholism; Deferoxamine; Diagnosis, Differential; Hemochromatosis; Humans; Iron; Iron Isotopes; Liv | 1967 |
[A case of hemochromatosis treated with desferrioxamine].
Topics: Adult; Deferoxamine; Hemochromatosis; Humans; Male | 1967 |
[Adiastole caused by a secondary cardiac hemochromatosis. Successful treatment with an iron chelating agent].
Topics: Adult; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Deferoxamine; Diastole; Echocardiography; Elec | 1983 |
Effect of ascorbic acid on desferrioxamine-induced urinary iron excretion in idiopathic hemochromatosis.
Topics: Adult; Ascorbic Acid; Deferoxamine; Female; Hemochromatosis; Humans; Iron; Male; Middle Aged; Time F | 1984 |
New diagnostic and therapeutic possibilities in manifest idiopathic hemochromatosis.
Topics: Bloodletting; Deferoxamine; Gastric Mucosa; Hemochromatosis; Humans; Liver; Magnetic Resonance Spect | 1984 |
Vitamin C, desferrioxamine and iron loading anemias.
Topics: Anemia; Ascorbic Acid; Deferoxamine; Genes, Recessive; Hemochromatosis; Humans; Intestinal Absorptio | 1984 |
[Idiopathic hemochromatosis--diagnosis and therapy].
Topics: Adult; Bloodletting; Carrier Proteins; Deferoxamine; Diagnosis, Differential; Ferritins; Hematocrit; | 1984 |
[The treatment of post-transfusional hemochromatosis with chelating agents].
Topics: Adult; Chelating Agents; Deferoxamine; Edetic Acid; Hemochromatosis; Humans; Male; Pentetic Acid; Tr | 1981 |
Iron overload: pathogenesis and treatment with chelating agents.
Topics: Blood Transfusion; Bloodletting; Chelating Agents; Deferoxamine; Hemochromatosis; Humans; Infusions, | 1983 |
Use of subcutaneous deferoxamine in a child with hemochromatosis associated with congenital dyserythropoietic anemia, type I.
Topics: Anemia, Dyserythropoietic, Congenital; Anemia, Hemolytic, Congenital; Biopsy; Child; Deferoxamine; F | 1982 |
Early iron overload in beta-thalassaemia major: when to start chelation therapy?
Topics: Child, Preschool; Deferoxamine; Hemochromatosis; Humans; Infant; Iron; Thalassemia; Transfusion Reac | 1982 |
Chelation therapy for iron overload.
Topics: Animals; Chelating Agents; Deferoxamine; Hemochromatosis; Hemosiderosis; Humans; Rats; Thalassemia | 1980 |
[Treatment and prevention of chronic iron overload (author's transl)].
Topics: Bloodletting; Deferoxamine; Hematologic Diseases; Hemochromatosis; Hemosiderosis; Humans; Iron; Live | 1981 |
[Iron-overload in patients on maintenance hemodialysis: diagnostic criteria, indications and treatment by desferrioxamine (author's transl)].
Topics: Adult; Aged; Biopsy, Needle; Deferoxamine; Female; Ferritins; Hemochromatosis; Hemosiderosis; Hepati | 1981 |
Iron overload in congenital erythrocyte pyruvate kinase deficiency.
Topics: Adult; Anemia, Hemolytic; Anemia, Hemolytic, Congenital; Deferoxamine; Erythrocytes; Hemochromatosis | 1980 |
Treatment of iron storage disorders.
Topics: Anemia; Deferoxamine; Hemochromatosis; Humans; Iron; Liver Cirrhosis; Porphyrias; Skin Diseases; Tha | 1980 |
Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods.
Topics: Deferoxamine; Female; Ferritins; Hemochromatosis; Humans; Iron; Liver; Liver Diseases, Alcoholic; Li | 1981 |
Hepatitis C virus infection and liver disease in children with thalassemia.
Topics: Adolescent; Adult; beta-Thalassemia; Chelation Therapy; Child; Child, Preschool; Combined Modality T | 1993 |
Reversal of haemochromatotic cardiomyopathy in beta thalassaemia by chelation therapy.
Topics: Adult; beta-Thalassemia; Cardiomyopathy, Dilated; Chelation Therapy; Deferoxamine; Female; Hemochrom | 1995 |
Recombinant human erythropoietin in the treatment of myelodysplastic syndromes--response patterns.
Topics: Aged; Aged, 80 and over; Anemia, Refractory; Anemia, Sideroblastic; Blood Transfusion; Chelation The | 1994 |
[Lymphocyte chemiluminescent activity under an iron overload of the body].
Topics: Antioxidants; Combined Modality Therapy; Deferoxamine; Dose-Response Relationship, Drug; Ferritins; | 1993 |
Sick sinus syndrome as the early manifestation of cardiac hemochromatosis.
Topics: Cardiac Pacing, Artificial; Deferoxamine; Electrocardiography; Electrocardiography, Ambulatory; Fema | 1994 |
[Post-transfusion hemochromatosis. Results of a study carried out in Blood Transfusion Centers. Analysis of 15 cases treated with subcutaneous perfusion of Desferal. Working group "Transfusion Techniques and Therapeutics"].
Topics: Deferoxamine; France; Hemochromatosis; Humans; Injections, Subcutaneous; Perfusion; Retrospective St | 1994 |
Iron overload and psychiatric illness.
Topics: Adult; Aged; Anxiety Disorders; Carrier Proteins; Deferoxamine; Dementia; Depressive Disorder; Diagn | 1994 |
Heart transplantation in a case of juvenile hereditary haemochromatosis followed up by MRI and endomyocardial biopsies.
Topics: Adult; Alanine Transaminase; Biomarkers; Biopsy; Deferoxamine; Diabetes Mellitus, Type 1; Ferritins; | 1993 |
Desferrioxamine therapy induces clearance of iron deposits after bone marrow transplantation for thalassemia: case report.
Topics: Adolescent; beta-Thalassemia; Chelation Therapy; Combined Modality Therapy; Deferoxamine; Ferritins; | 1993 |
Liver iron overload and liver fibrosis in thalassemia.
Topics: Adolescent; Adult; Chelation Therapy; Child; Child, Preschool; Combined Modality Therapy; Deferoxami | 1993 |
Multiple hormone deficiencies in children with hemochromatosis.
Topics: Adolescent; Child; Deferoxamine; Endocrine System Diseases; Female; Follicle Stimulating Hormone; Go | 1993 |
Hyperpigmentation and secondary hemochromatosis: a novel treatment with extracorporeal chelation.
Topics: Chelation Therapy; Deferoxamine; Female; Hemochromatosis; Humans; Hyperpigmentation; Iron; Middle Ag | 1993 |
High-dose intravenous desferrioxamine (DFO) delivery in four thalassemic patients allergic to subcutaneous DFO administration.
Topics: Adolescent; Adult; beta-Thalassemia; Catheters, Indwelling; Chelation Therapy; Deferoxamine; Drug Hy | 1996 |
Management of iron overload with a disposable multi-day delivery system.
Topics: Adolescent; Catheters, Indwelling; Chelation Therapy; Child; Deferoxamine; Disposable Equipment; Hem | 1996 |
Long-term intraperitoneal deferoxamine for hemochromatosis.
Topics: Adult; Cardiomyopathies; Deferoxamine; Female; Hemochromatosis; Humans; Injections, Intraperitoneal; | 1996 |
Logarithmic quantitation model using serum ferritin to estimate iron overload in secondary haemochromatosis.
Topics: Adolescent; Anemia; Child; Child, Preschool; Deferoxamine; Erythrocyte Transfusion; Ferritins; Hemoc | 1996 |
[Long-term efficacy of subcutaneous administration of deferoxamine in patients with secondary hemochromatosis].
Topics: Aged; Anemia, Aplastic; Deferoxamine; Female; Hemochromatosis; Humans; Injections, Subcutaneous; Mal | 1996 |
[Ocular side effects of deferoxamine therapy in aplastic anemia with transfusion-induced hemochromatosis].
Topics: Anemia, Aplastic; Blood Transfusion; Child; Deferoxamine; Electroretinography; Evoked Potentials, Vi | 1996 |
Continuous low-dose subcutaneous desferrioxamine (DFO) to prevent allergic manifestations in patients with iron overload.
Topics: Adult; Biopsy; Cell Degranulation; Chelating Agents; Deferoxamine; Dose-Response Relationship, Drug; | 1996 |
Reversible severe hereditary hemochromatotic cardiomyopathy.
Topics: Adult; Cardiomyopathies; Deferoxamine; Hemochromatosis; Humans; Male; Phlebotomy; Severity of Illnes | 1997 |
[Therapy of transfusion hemochromatosis].
Topics: Blood Transfusion; Deferoxamine; Hemochromatosis; Humans; Injections, Subcutaneous; Myelodysplastic | 1997 |
Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies.
Topics: Acetylcysteine; Alprostadil; Antioxidants; Chelating Agents; Deferoxamine; Hemochromatosis; Humans; | 1998 |
Hereditary juvenile haemochromatosis: a genetically heterogeneous life-threatening iron-storage disease.
Topics: Adolescent; Adult; Age of Onset; Chelating Agents; Deferoxamine; Endocrine System Diseases; Female; | 1998 |
Hemochromatosis and vitamin C.
Topics: Ascorbic Acid; Chelating Agents; Deferoxamine; Dietary Supplements; Drug Therapy, Combination; Hemoc | 1999 |
Juvenile hemochromatosis associated with B-thalassemia treated by phlebotomy and recombinant human erythropoietin.
Topics: Adrenal Cortex Hormones; Adrenal Insufficiency; Adult; Arrhythmias, Cardiac; beta-Thalassemia; Chela | 2000 |
Prevention of iron loading in transfusion-dependent thalassaemia.
Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; Deferoxamine; Dose-Response Relationship, D | 1978 |
Recent advances in iron metabolism.
Topics: Anemia, Hypochromic; Deferoxamine; Ferritins; Hemochromatosis; Humans; Intestinal Absorption; Iron; | 1979 |
[Idiopathic hemochromatosis: current problems in diagnosis and therapy].
Topics: Adolescent; Adult; Aged; Biopsy; Cobalt; Deferoxamine; Female; Ferritins; Hemochromatosis; Humans; I | 1979 |
Increased risk of diabetes mellitus in beta- thalassemia major due to iron overload.
Topics: Adolescent; Arginine; Blood Glucose; Child; Child, Preschool; Deferoxamine; Diabetes Mellitus, Type | 1979 |
Arthropathy as the major clinical indicator of occult iron storage disease.
Topics: Adult; Arthritis; Cartilage, Articular; Chronic Disease; Deferoxamine; Female; Hemochromatosis; Hemo | 1977 |
Deferoxamine-chelatable iron in hemochromatosis and other disorders of iron overload.
Topics: Adult; Anemia; Chronic Disease; Deferoxamine; Hemochromatosis; Humans; Iron; Iron Chelating Agents; | 1978 |
Preclinical hemochromatosis in a population on a high-iron-fortified diet.
Topics: Adult; Deferoxamine; Female; Food, Fortified; Hemochromatosis; Humans; Iron; Male; Risk; Sex Factors | 1978 |
Continuous intravenous deferoxamine infusion. Treatment of secondary hemochromatosis in adults.
Topics: Administration, Oral; Adult; Aged; Ascorbic Acid; Deferoxamine; Female; Hemochromatosis; Humans; Inf | 1978 |
[Further experiences with iron-chelating therapy (desferrioxamine and ascorbic acid) in siderochromatosis and Cooley's disease].
Topics: Adolescent; Adult; Aged; Ascorbic Acid; Deferoxamine; Drug Evaluation; Female; Hemochromatosis; Hemo | 1978 |
Treatment of primary hemochromatosis with deferoxamine.
Topics: Adult; Arrhythmias, Cardiac; Deferoxamine; Female; Heart Failure; Hemochromatosis; Humans; Male; Ped | 1979 |
Iron absorption in normal subjects and patients with idiopathic haemochromatosis: relationship with serum ferritin concentration.
Topics: Adult; Deferoxamine; Female; Ferritins; Hemochromatosis; Hemoglobins; Humans; Intestinal Absorption; | 1975 |
Pathogenesis and management of iron overload in thalassemia.
Topics: Deferoxamine; Hemochromatosis; Humans; Iron; Pentetic Acid; Thalassemia | 1975 |
[Iron storage disease].
Topics: Deferoxamine; Diagnosis, Differential; Hemochromatosis; Humans; Siderosis | 1977 |
Heredity of idiopathic haemochromatosis: a study of 106 families.
Topics: Adolescent; Adult; Aged; Blood Glucose; Consanguinity; Deferoxamine; Diseases in Twins; Female; Gene | 1977 |
Idiopathic hemochromatosis: case report of a patient presenting with neurologic symptoms.
Topics: Aged; Deferoxamine; Diabetes Mellitus; Female; Heart Failure; Hemochromatosis; Humans; Iron; Liver C | 1977 |
Hereditary hemochromatosis. Diagnosis in siblings and children.
Topics: Adolescent; Adult; Age Factors; Aged; Deferoxamine; Female; Ferritins; Hemochromatosis; Humans; Iron | 1977 |
A family study of a patient with idiopathic hemochromatosis.
Topics: Cobalt Radioisotopes; Deferoxamine; Hemochromatosis; Humans; Iron; Male; Middle Aged; Urine | 1977 |
[Mechanism of action of desferrioxamine].
Topics: Deferoxamine; Depression, Chemical; Hemochromatosis; Humans; Injections, Intramuscular; Iron; Liver; | 1975 |
[Letter: Therapy of hemochromatosis].
Topics: Bloodletting; Deferoxamine; Hemochromatosis; Humans; Porphyrias; Siderosis | 1975 |
Studies of in vivo iron mobilization by chelators in the ferrocene-loaded rat.
Topics: Animals; Brain; Deferiprone; Deferoxamine; Disease Models, Animal; Ferrous Compounds; Heart; Hemochr | 1992 |
[A case of idiopathic hemochromatosis associated with gastric cancer].
Topics: Adenocarcinoma; Aged; Deferoxamine; Fibrosis; Hemochromatosis; Humans; Liver; Male; Stomach Neoplasm | 1992 |
Change in the thyroid function by use of deferoxamine in a patient with hemochromatosis complicated by hyperthyroidism.
Topics: Aged; Deferoxamine; Female; Hemochromatosis; Humans; Hyperthyroidism; Propylthiouracil; Thyroid Func | 1992 |
[Intensifying iron chelating therapy with desferrioxamine using implantable venous access catheters (Port-A-Cath)].
Topics: Acute-Phase Reaction; Adolescent; Adult; Catheters, Indwelling; Deferoxamine; Female; Heart Failure; | 1992 |
Iron chelation.
Topics: Chelation Therapy; Deferiprone; Deferoxamine; Hemochromatosis; Humans; Iron; Iron Chelating Agents; | 1991 |
[Yersinia enterocolitica septicemia associated with idiopathic hemochromatosis and deferoxamine therapy. A case].
Topics: Deferoxamine; Hemochromatosis; Humans; Infusions, Intravenous; Male; Middle Aged; Risk Factors; Seps | 1991 |
[The characteristics of the clinical course of hereditary hemochromatosis].
Topics: Bloodletting; Combined Modality Therapy; Deferoxamine; Female; Hemochromatosis; Humans; Male; Remiss | 1991 |
Iron overload in psychiatric illness.
Topics: Deferoxamine; Hemochromatosis; Humans; Iron; Mental Disorders | 1991 |
Cardiac alterations in 36 consecutive patients with idiopathic haemochromatosis: polygraphic and echocardiographic evaluation.
Topics: Adult; Bloodletting; Cardiomyopathies; Deferoxamine; Echocardiography; Echocardiography, Doppler; El | 1991 |
Ferrioxamine and its hexadentate iron-chelating metabolites in human post-desferal urine studied by high-performance liquid chromatography and fast atom bombardment mass spectrometry.
Topics: Chromatography, High Pressure Liquid; Deferoxamine; Edetic Acid; Ferric Compounds; Gas Chromatograph | 1990 |
Cystic fibrosis in a black child with hemoglobin S-D disease.
Topics: Black People; Child; Cystic Fibrosis; Deferoxamine; Female; Hemochromatosis; Hemoglobinopathies; Hem | 1990 |
Four-hour measurement of urinary iron excretion after deferoxine treatment: a rapid, simple method for study of iron excretion.
Topics: Deferoxamine; Hemochromatosis; Humans; Iron; Time Factors | 1990 |
Granulocyte dysfunction in patients with iron overload.
Topics: Cell Movement; Deferoxamine; Hemochromatosis; Humans; Neutrophils | 1990 |
Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy.
Topics: Acetates; Bleomycin; Chlorides; Chromatography, High Pressure Liquid; Citrates; Citric Acid; Deferox | 1989 |
Genetic hemochromatosis: distribution analysis of six laboratory measures of iron metabolism.
Topics: Deferoxamine; Female; Ferritins; Genetic Linkage; Hemochromatosis; HLA Antigens; Humans; Iron; Male; | 1989 |
[Continuous subcutaneous desferrioxamine injection in primary idiopathic hemochromatosis with macrocytic anemia].
Topics: Adult; Anemia, Macrocytic; Deferoxamine; Female; Genetic Markers; Hemochromatosis; Humans; Injection | 1989 |
[Treatment of post-transfusion iron overload by deferoxamine].
Topics: Adolescent; Adult; Anemia, Sickle Cell; Child; Deferoxamine; Ferritins; Hemochromatosis; Humans; Tha | 1989 |
Studies of variations of subcutaneously infused desferrioxamine and iron movements in thalassaemia children.
Topics: Adolescent; Child; Deferoxamine; Female; Ferric Compounds; Hemochromatosis; Humans; Infusions, Paren | 1989 |
Biochemical studies of the iron cores and polypeptide shells of haemosiderin isolated from patients with primary or secondary haemochromatosis.
Topics: Deferoxamine; Ferritins; Hemochromatosis; Hemosiderin; Humans; Iron; Liver; Molecular Weight; Spleen | 1989 |
Concomitant primary hemochromatosis and beta-thalassemia trait: iron depletion by erythrocytapheresis and desferrioxamine.
Topics: Adult; Blood Component Removal; Deferoxamine; Erythrocytes; Female; Ferritins; Hemochromatosis; Huma | 1989 |
Diagnosis and treatment of iron overload in paediatric patients on chronic haemodialysis.
Topics: Adolescent; Adult; Alanine Transaminase; Child; Child, Preschool; Deferoxamine; Female; Ferritins; H | 1988 |
The effect of iron fortification of the diet on clinical iron overload in the general population.
Topics: Administration, Oral; Adolescent; Adult; Biopsy, Needle; Deferoxamine; Diet; Female; Ferritins; Food | 1988 |
[Diagnosis of primary hemochromatosis].
Topics: Biopsy; Bloodletting; Deferoxamine; Diagnosis, Differential; Ferritins; Hemochromatosis; HLA Antigen | 1988 |
[Therapy of hemochromatosis].
Topics: Bloodletting; Deferoxamine; Ferritins; Hemochromatosis; Humans; Prognosis; Time Factors | 1988 |
Gallium-67 scintigraphy in patients with hemochromatosis treated by deferoxamine.
Topics: Citrates; Citric Acid; Deferoxamine; Female; Gallium Radioisotopes; Hemochromatosis; Humans; Male; M | 1988 |
Pharmacokinetics and renal elimination of desferrioxamine and ferrioxamine in healthy subjects and patients with haemochromatosis.
Topics: Adult; Aluminum; Deferoxamine; Female; Ferric Compounds; Hemochromatosis; Humans; Injections, Intram | 1987 |
Iron overload and mobilization in long-term hemodialysis patients.
Topics: Adult; Bone Diseases; Child; Deferoxamine; Erythrocyte Transfusion; Female; Ferritins; Hemochromatos | 1987 |
Heart cells in culture: a model of myocardial iron overload and chelation.
Topics: Animals; Cells, Cultured; Chelating Agents; Deferoxamine; Ferritins; Heart Diseases; Hemochromatosis | 1985 |
Chelating agents in medicine.
Topics: Chelating Agents; Chemistry, Pharmaceutical; Deferoxamine; Dicumarol; Edetic Acid; Hemochromatosis; | 1971 |
Effect of phenylhydrazine-induced haemolysis on the urinary excretion of iron after desferrioxamine.
Topics: Anemia, Sideroblastic; Animals; Biopsy; Bone Marrow Examination; Deferoxamine; Feces; Guinea Pigs; H | 1967 |
Assessment of body-iron stores in cirrhosis and haemochromatosis with the differential ferrioxamine test.
Topics: Adolescent; Adult; Aged; Chelating Agents; Deferoxamine; Diagnosis, Differential; Female; Hemochroma | 1967 |
Iron metabolism by reticuloendothelial cells in vitro. Physical and chemical conditions, lipotrope deficiency, and acute inflammation.
Topics: Animals; Ascorbic Acid; Cobalt; Copper; Cysteine; Dactinomycin; Deferoxamine; Dinitrophenols; Edetic | 1969 |
[Comparative studies on the efficacy of chelating agents in experimental iron storage disease in the rat].
Topics: Animals; Body Weight; Chelating Agents; Deferoxamine; Female; Hemochromatosis; Iron; Liver; Liver Ci | 1967 |
[The desferrioxamine B induced hypersideruria test in hemochromatosis].
Topics: Deferoxamine; Hemochromatosis; Humans; Urine | 1965 |
[Infectious mononucleosis with pulmonary, pleural and mediastinal involvement].
Topics: Adult; Agglutination Tests; Deferoxamine; Hemochromatosis; Hepatitis A; Hepatomegaly; Humans; Infect | 1969 |
The identification of 2, 3-dihydroxybenzoic acid as a potentially useful iron-chelating drug.
Topics: Administration, Oral; Animals; Ascorbic Acid; Benzoates; Blood Transfusion; Body Weight; Calcium; Ca | 1974 |
[Treatment of primary idiopathic hemochromatosis and secondary hemosiderosis].
Topics: Bloodletting; Deferoxamine; Hemochromatosis; Hemosiderosis; Humans; Iron; Male; Prognosis | 1974 |
Primary hemochromatosis: easily missed cause of cirrhosis, diabetes and heart failure.
Topics: Age Factors; Aged; Blood Cell Count; Bloodletting; Deferoxamine; Diabetes Mellitus; Female; Heart Fa | 1973 |
Iron excess, early glucose intolerance and impaired insulin secretion in idiopathic haemochromatosis.
Topics: Adolescent; Adult; Age Factors; Blood Glucose; Deferoxamine; Diabetes Mellitus; Female; Glucose Tole | 1973 |
[Diagnosis and therapy of iron-deficiency and sideroachrestic anemias].
Topics: Anemia, Hypochromic; Anemia, Macrocytic; Bloodletting; Deferoxamine; Hemochromatosis; Humans; Iron; | 1973 |
[The treatment of idiopathic hemochromatosis by means of blood removal and chelates (author's transl)].
Topics: Adult; Bloodletting; Deferoxamine; Follow-Up Studies; Hemochromatosis; Humans; Male; Middle Aged | 1974 |
[Temporary blindness in hemochromatosis].
Topics: Biopsy; Blindness; Deferoxamine; Hemochromatosis; Humans; Injections, Intramuscular; Liver; Liver Ci | 1974 |
Idiopathic haemochromatosis: an autosomal recessive disease.
Topics: Adolescent; Adult; Aged; Child; Chromosome Aberrations; Chromosome Disorders; Deferoxamine; Female; | 1974 |
[Disorders of iron metabolism in liver patients].
Topics: Adult; Anemia; Biopsy; Deferoxamine; Feces; Female; Hemochromatosis; Humans; Iron; Iron Isotopes; Li | 1966 |
Effect of desferrioxamine methansulphonate (DFOM) on glucose uptake by rat epididymal adipose tissue.
Topics: Adipose Tissue; Animals; Deferoxamine; Diabetes Mellitus; Edetic Acid; Glucose; Hemochromatosis; In | 1966 |
[Idiopathic hemochromatosis. Therapeutics].
Topics: Alcoholism; Bloodletting; Chelating Agents; Deferoxamine; Edetic Acid; Hemochromatosis; Humans; Live | 1967 |
[The diagnostic value of the desferrioxamine B test in the latent form of primary idiopathic hemochromatosis].
Topics: Adolescent; Adult; Child; Deferoxamine; Edetic Acid; Female; Hemochromatosis; Humans; Iron; Male; Mi | 1966 |
Diagnosis of iron storage disease with desferrioxamine (Desferal test).
Topics: Anemia, Macrocytic; Anemia, Sickle Cell; Deferoxamine; Female; Hemochromatosis; Hemosiderosis; Human | 1964 |
[Desferal test in the diagnosis of familial hemochromatosis].
Topics: Adult; Deferoxamine; Female; Hemochromatosis; Humans; Male; Middle Aged | 1972 |
[Hemochromatosis].
Topics: Adult; Anemia, Macrocytic; Bloodletting; Deferoxamine; Diagnosis, Differential; Diet Therapy; Female | 1972 |
[Iron kinetics in hemochromatosis].
Topics: Autoradiography; Bloodletting; Deferoxamine; Diagnosis, Differential; Erythrocytes; Erythropoiesis; | 1972 |
[Present aspects of the treatment of hemochromatosis (apropos of 100 observations)].
Topics: Adult; Alcoholic Intoxication; Bloodletting; Chelating Agents; Chondrocalcinosis; Deferoxamine; Diab | 1971 |
The effect of desferrioxamine B upon the enzymatic catalase and PPD-oxydase activity in plasma and serum.
Topics: Catalase; Copper; Deferoxamine; Enzymes; Hemochromatosis; Humans; In Vitro Techniques; Iron; Oxidore | 1966 |
Studies on iron metabolism with desferrioxamine in man. Experimental and clinical studies.
Topics: Adult; Aged; Allopurinol; Anemia, Hypochromic; Blood Transfusion; Deferoxamine; Diet; Erythrocytes; | 1969 |
A comparison of desferrioxamine-induced sideruria and measurement of labile iron store as indices of body iron status.
Topics: Adult; Anemia, Hypochromic; Anemia, Macrocytic; Autoanalysis; Body Composition; Chelating Agents; De | 1971 |
[Therapy of primary siderochromatosis and siderosis: experimental and clinical study].
Topics: Bloodletting; Deferoxamine; Hemochromatosis; Humans; Intestinal Absorption; Iron; Porphyrias; Primar | 1969 |
The effect of ascorbic acid deficiency on desferrioxamine-induced urinary iron excretion.
Topics: Ascorbic Acid; Ascorbic Acid Deficiency; Deferoxamine; Hemochromatosis; Humans; Iron; Leukocytes; Ma | 1969 |
Differential ferrioxamine test in haemochromatosis and liver diseases.
Topics: Adult; Bloodletting; Cholestasis; Deferoxamine; Diagnosis, Differential; Female; Hemochromatosis; Hu | 1969 |
Ferrioxamine iron in rabbit reticulocyte heme synthesis.
Topics: Amino Acids; Animals; Biological Transport; Cell Membrane; Cell Membrane Permeability; Deferoxamine; | 1970 |
[Case of primary haemochromatosis and therapeutic effect of desferrioxamine].
Topics: Biopsy; Deferoxamine; Hemochromatosis; Humans; Liver; Male; Middle Aged; Skin | 1970 |
[Post-desferrioxamine urinary iron in iron-overload states].
Topics: Adult; Aged; Deferoxamine; Hemochromatosis; Humans; Iron; Middle Aged; Spectrophotometry | 1970 |
Storage iron and desferrioxamine.
Topics: Adolescent; Adult; Age Factors; Aged; Anemia, Hemolytic; Anemia, Hypochromic; Anemia, Macrocytic; De | 1970 |
Iron overload in haemochromatosis.
Topics: Adult; Arthritis; Ascorbic Acid; Biopsy; Bloodletting; Deferoxamine; Female; Gastric Juice; Hemochro | 1970 |
[Hemosiderosis and idiopathic hemochromatosis].
Topics: Bloodletting; Deferoxamine; Diagnosis, Differential; Hemochromatosis; Hemosiderosis; Humans; Iron; I | 1967 |
[Hemochromatosis and its modern treatment].
Topics: Deferoxamine; Female; Hemochromatosis; Humans; Male | 1967 |
[Deferoxamine-B test. Evaluation of the organism's iron content by loading with a ferriuretic chelate].
Topics: Adolescent; Adult; Age Factors; Aged; Bone Marrow; Child; Deferoxamine; Female; Hemochromatosis; Hem | 1967 |
[Contribution to the study of intestinal absorption of inorganic and dietary iron by means of Fe59 in healthy subjects, patients with hemochromatosis and cirrhosis, before and after treatment with Desferal].
Topics: Deferoxamine; Hemochromatosis; Humans; Intestinal Absorption; Iron; Iron Isotopes; Liver Cirrhosis | 1967 |
[On the usefulness of iron kinetics studied with Fe59 in the differential diagnosis of idiopathic siderochromatosis and that secondary to liver diseases].
Topics: Adult; Deferoxamine; Hemochromatosis; Hemosiderosis; Humans; Iron; Iron Isotopes; Liver Diseases; Mi | 1967 |
[Iron storage disease].
Topics: Adult; Anemia; Child; Deferoxamine; Female; Hemochromatosis; Humans; Iron; Liver Diseases; Male; Mid | 1967 |
[Favorable effect of desferal on the clinical course of hemochromatosis].
Topics: Adult; Deferoxamine; Hemochromatosis; Humans; Male | 1968 |
Evaluation of storage iron by chelates.
Topics: Anemia; Animals; Bone Marrow; Deferoxamine; Feces; Hemochromatosis; Humans; Iron; Iron Isotopes; Liv | 1968 |
[Use of desferal and some data on hemosiderosis in hypo- and aplastic anemias].
Topics: Acute Disease; Adolescent; Adult; Anemia, Aplastic; Chronic Disease; Deferoxamine; Female; Hemochrom | 1968 |
Studies on the diabetic syndrome of idiopathic haemochromatosis.
Topics: Adult; Aged; Blood Glucose; Deferoxamine; Diabetes Mellitus; Glucose Tolerance Test; Hemochromatosis | 1968 |
[Deferoxamine].
Topics: Animals; Deferoxamine; Hemochromatosis; Humans; Iron; Poisoning | 1969 |
Clinical and laboratory studies on the action of desferrioxamine.
Topics: Animals; Deferoxamine; Diet; Feces; Ferritins; Hemochromatosis; Humans; Intestinal Mucosa; Iron; Kid | 1969 |
[Effect of desferrioxamine B and 2-(beta-aminoethoxy)cyclohexylaminetetraacetate in experimental hemochromatosis in rats and in primary hemochromatosis of man].
Topics: Aged; Animals; Chelating Agents; Deferoxamine; Female; Hemochromatosis; Humans; Iron; Male; Rats; St | 1969 |
Current therapeutics. 213. Desferrioxamine.
Topics: Deferoxamine; Hemochromatosis; Iron | 1965 |
[First results of a new iron chelating agent in the treatment of post-transfusional hemochromatosis].
Topics: Adolescent; Child; Child, Preschool; Deferoxamine; Hemochromatosis; Humans; Transfusion Reaction | 1965 |
[Use of desferrioxamine B in normal subjects and in patients with increased iron storage].
Topics: Adolescent; Adult; Child; Deferoxamine; Hemochromatosis; Hemosiderosis; Humans; In Vitro Techniques | 1965 |
[Demonstration of increased iron storage in the organism with desferrioxamine (desferal test)].
Topics: Deferoxamine; Hemochromatosis; Hemosiderosis; Humans; Iron; Jaundice; Liver Diseases; Porphyrias | 1965 |
Iron chelation in acute iron poisoning and chronic hypersiderosis.
Topics: Adolescent; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Deferoxamine; Female; H | 1965 |
[Desferal in the treatment of hemochromatosis].
Topics: Deferoxamine; Hemochromatosis; Humans | 1965 |
[Clinically isolated cardiac hemochromatosis treated with success by desferrioxamine].
Topics: Adult; Cardiomyopathies; Deferoxamine; Hemochromatosis; Humans; In Vitro Techniques; Male | 1965 |
[Effect of the ion-exchange resin desferrioxamine B on iron metabolism].
Topics: Deferoxamine; Hemochromatosis; Humans | 1965 |
[Specific treatment of excessive iron deposition in the tissues].
Topics: Administration, Oral; Bloodletting; Chelating Agents; Connective Tissue; Deferoxamine; Hemochromatos | 1965 |
[Immunological demonstration of the reversible binding of Fe 59 to transferrin].
Topics: Animals; Antigen-Antibody Reactions; Deferoxamine; Hemochromatosis; Humans; Immune Sera; Iron; Iron | 1963 |
Differential ferrioxamine test in idiopathic haemochromatosis and transfusional haemosiderosis.
Topics: Adolescent; Adult; Aged; Anemia, Hemolytic; Biopsy; Blood Chemical Analysis; Bloodletting; Deferoxam | 1966 |
Effects of desferrioxamine in patients with iron-loading with a simple method for estimating urinary iron.
Topics: Anemia, Hypochromic; Anemia, Sideroblastic; Deferoxamine; Hemochromatosis; Humans; In Vitro Techniqu | 1966 |
Sideruria following a single dose of desferrioxamine-B as a diagnostic test in iron overload.
Topics: Adult; Anemia, Hemolytic; Blood; Bone Marrow; Deferoxamine; Female; Hemochromatosis; Hemosiderosis; | 1966 |
Simplified deferoxamine test in normal, diabetic, and iron-overload patients. Clinical observations.
Topics: Adult; Aged; Blood; Deferoxamine; Diabetes Mellitus; Female; Hemochromatosis; Hemoglobins; Humans; I | 1966 |
Transferrin behaviour in haemochromatosis.
Topics: Deferoxamine; Hemochromatosis; Hemosiderosis; Hepatitis A; Humans; Iron; Liver; Liver Cirrhosis; Mid | 1966 |
[A case of primary hemochromatosis treated with desferol].
Topics: Aged; Carbohydrate Metabolism; Deferoxamine; Diabetes Mellitus; Hemochromatosis; Humans; Iron; Male | 1966 |
[Respective variations of iron in blood and urine in cirrhotic and alcoholic patients after a desferrioxamine test].
Topics: Alcoholism; Deferoxamine; Diagnosis, Differential; Female; Hemochromatosis; Humans; Iron; Liver Cirr | 1966 |
[Desferal-test and hemochromatosis].
Topics: Adult; Aged; Deferoxamine; Hemochromatosis; Humans; Male; Middle Aged | 1966 |
The treatment of hemosiderosis in thalassaemia major with desferrioxamine-B.
Topics: Adolescent; Anemia, Sickle Cell; Biopsy; Child; Deferoxamine; Female; Hemochromatosis; Hemosiderosis | 1966 |
[Contribution to the problem of hemochromatosis].
Topics: Adult; Deferoxamine; Female; Ferritins; Hemochromatosis; Humans; Injections, Intramuscular; Insulin; | 1966 |